{"Title": ["AMRN August 7th Options Begin Trading", "Amarin (AMRN) Stock Will Likely Stay Range-Bound Near-Term, Says Analyst", "Can Amarin Soar 420% Over the Next Year? This Analyst Thinks So", "AMRN Makes Peace With Apotex, IDYA Cuts Deal With GSK, SLRX On Watch, NBIX, TAK Ink $2Bln Pact", "A Stock to Play in a 'Risk-Irrelevant' Market", "PPH's Holdings Imply 21% Gain Potential", "July 31st Options Now Available For Amarin (AMRN)", "Too Much Uncertainty Keeps This 5-Star Analyst Watching Amarin Stock From the Sidelines", "AMRN August 7th Options Begin Trading", "July 10th Options Now Available For Amarin (AMRN)", "BUZZ-U.S. STOCKS ON THE MOVE-LiveRamp, T2 Biosystems, Foot locker", "FDA Approves Generic Version of Amarin's Blockbuster Fish Oil Capsules", "BUZZ-U.S. STOCKS ON THE MOVE-Abbott, Tetraphase Pharma, HPE", "1 Biotech Stock to Avoid at All Costs", "FDA Approves First Generic Version Of Vascepa; Amarin On Watch", "Is Amarin Stock a Buy?", "Will Courts Reverse Earlier Ruling on Amarin Patents? Analyst Weights In", "If You Invested $10,000 in Amarin's IPO, This Is How Much Money You'd Have Now", "Amarin (AMRN) Stock Could Stage a Rebound to $15, Says Analyst", "Amarin (AMRN): All Eyes on Vascepa Appeal Verdict", "Amarin Corporation plc (AMRN) Q1 2020 Earnings Call Transcript", "BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Valaris, QEP Resources", "BUZZ-U.S. STOCKS ON THE MOVE-Tesla, Facebook, Valaris", "2 Top Biotech Stocks Under $10", "Can Amarin (AMRN) Overcome Its Patent Headwinds? 5-Star Analyst Weighs In", "Can Amarin's Stock Recover From Its 70% Implosion?", "Should You Buy Biotech Stocks Right Now?", "BUZZ-U.S. STOCKS ON THE MOVE-Wall St banks, U.S. airlines, casinos, Tesla, J&J, Apple, Roku", "AMRN Chugs Along, ATHX To Initiate Pivotal COVID-19 Trial, WORX Soars 550%", "Amarin Corporation plc (AMRN) Q1 2020 Earnings Call Transcript", "Why Amarin Stock Is on the Mend Today", "Amarin (AMRN) Will Make Excellent Takeover Target, Says Analyst", "Better Buy: Amarin vs. Aurinia Pharmaceuticals", "Why Is Everyone Talking About Amarin Stock?", "Are Amarin's Blockbuster Dreams Over?", "2 Ultra-High-Growth Stocks I'd Buy Right Now", "What's The Buzz About Amarin Corp. (AMRN)?", "Why Did Amarin's Stock Fall Off a Cliff?", "Judge\u2019s Record Looks Unpromising for Amarin\u2019s Appeal; Analyst Remains Bullish", "Is Amarin Stock a Buy?", "Why Amarin Stock Imploded in March", "Why Amarin Stock Is Crashing Today", "Health Care Sector Update for 03/31/2020: AMRN, PSTV, PHGE, JNJ, PFE, ABT, MRK, AMGN", "AMRN Loses Legal Fight, AKRO Awaits Big Day, JNJ's Covid-19 Vaccine Study In Sep", "Shares of Amarin Down 68% After Losing a Patent Lawsuit for Vascepa", "My Top 7 Stocks to Buy in March's Stock Market Crash", "Even If It Hurts Amarin Stock, Reducing the Vascepa Sales Push Is Smart", "3 Stocks to Buy After the Coronavirus Crash", "Judicial Ruling Guts Amarin (AMRN) Stock; What\u2019s Next?", "Goldman Sachs: 3 Stocks to Snap up on the Dip", "Amarin Pulls Back Sales Force Amid Coronavirus Pandemic", "With the Market Down, I'm Buying These 3 Stocks", "Why It\u2019s the Perfect Time to Buy Amarin Stock Now", "Why Amarin Stock Plunged in February", "6 Quality Biotech Stocks on Sale Now", "Amarin Stock Looks Like a Heart-Healthy Buy on the Dip", "FDA to Postpone Some Inspections of U.S. Manufacturing Facilities", "Amarin Stock: When Good Results Aren\u2019t Enough", "Analysts Anticipate ADRU Will Reach $25", "3 Big Stock Charts for Tuesday: Amarin, Campbell Soup, and Church & Dwight", "Look Anywhere but Acasti Pharma Stock for Opportunity", "Confounding Decline Creates an Opportunity in Amarin Stock", "Amarin is Now Oversold (AMRN)", "4 Top Stock Trades for Thursday: AMRN, LOW, BAC, CCL", "Interesting AMRN Put And Call Options For April 24th", "Amarin: Is It Time to Test the Waters?", "Even Though It\u2019s Risky, Amarin Stock Is a Worthwhile Buy", "Acasti Pharma Is a Risky Play After Releasing Disappointing Data", "Amarin Corporation plc (AMRN) Q4 2019 Earnings Call Transcript", "Amarin Reports Q4 Results, Beats Earnings and Revenue Targets", "First-Mover Advantage Will Benefit Amarin Stock More Than You Think", "Why Amarin Stock Is Getting No Love Early in 2020", "Is It Time to Give Up on Amarin Stock After Earnings?", "6 Healthcare Stocks That Could Make You Filthy Rich", "Vascepa Growth Will Power Amarin Stock Way Higher in 2020", "Risks Remain, but Amarin Stock Is a Buy at Today\u2019s Prices", "Amarin\u2019s Vascepa Is a Great Story Filled With Too Many Unknowns", "Will Positive Patent News Send Amarin Stock Higher? Analysts Fight It Out", "Bears Are Now in Control of Amarin Stock, But Not for Long", "4 Dates Biotech Investors Should Circle in February", "Positive Catalysts Make Amarin Stock a Buy on Current Weakness", "Why Amarin Stock Lost 13.4% in January", "Consider Adding Amarin to Your Portfolio as Its Competition Falters", "Acasti Pharma Stock Has One Last Chance", "Amarin Stock Will Deliver More Upside for Patient Investors", "Could Amarin Be a Millionaire Maker Stock?", "Analysts Expect ADRU Will Reach $24", "Amarin Stock Projections Are Based on Hype and Hope", "Does the Recent Amarin Stock Pullback Put Shares in the Buy Category?", "Interesting AMRN Put And Call Options For March 6th", "A Tale of 3 Healthcare Stocks \u2013 2 to Buy, and 1 to Sell", "Where Will Intercept Pharmaceuticals Be in 5 Years?", "2 Mid-Cap Biotech Stocks to Buy Right Now", "How Much Is Amarin Really Worth?", "It\u2019s Time to Go Long Amarin Stock After Recent Headlines", "Why Amarin Stock Is Poised for a Healthy 2020", "Amarin Stock is Still Fully Valued Despite All the Good News", "AstraZeneca\u2019s Loss is Amarin\u2019s Big Gain This Year", "Good News for Amarin: AstraZeneca Abandoning its Fish Oil Pill", "Acasti Pharma Stock Could Soar Above $3 Soon", "2020 J.P. Morgan Healthcare Conference Roundup", "All the 2020 Pre-JPM News Healthcare Investors Need to Know", "Amarin Stock Bouncing Back After Revised Results and 2020 Guidance", "7 Healthcare Stocks to Buy or Sell As Pricing Pressures Mount", "After FDA Approval, Amarin Stock Is Stuck in Worrisome Trading", "September 18th Options Now Available For Amarin (AMRN)", "A Recent FDA Approval Will Be Huge in Moving Amarin Stock", "Here's Why Matinas BioPharma Shares Lost as Much as 16.9% Today", "Amarin Reports Preliminary Vascepa Sales, Projects Further Growth In 2020", "Amarin Corporation (AMRN): All Eyes on Vascepa 2020 Sales", "3 High-Growth Stocks That Can Soar", "Is Amarin Stock a Top Pick for 2020?", "All Bets Are Off for Amarin Stock", "September 18th Options Now Available For Amarin (AMRN)", "3 Top Biotech Stocks to Buy in January", "AMRN February 14th Options Begin Trading", "Health Care Sector Update for 12/31/2019: AMRN,HLS.TO,NVCN,NVCN.TO,IMAC,ONTX", "Vascepa\u2019s Future Looks Rosy, But It Could Still Be Fishy for Amarin Stock", "Health for Patients, Wealth for Investors: Watch Amarin Stock Closely", "Amarin Stock Will Keep Powering Higher In 2020", "Amarin Stock Primed for New Highs", "3 Stocks That Could Be the Next Biotech Buyouts", "Amarin Stock is at Sky-High Levels Already Assumes All the Good News", "Why Longer-Term Investors Should Buy Amarin Stock on Weakness", "Amarin Has the Kind of Future Worth the Near-Term Choppiness", "3 Risks Amarin Still Faces After Its Huge FDA Win for Vascepa", "Why Matinas BioPharma Tumbled 13.4% Today", "Analyst: With FDA Approval Already Priced In, Avoid Amarin (AMRN) Stock", "The Success of Vascepa Actually Might Be a Problem for Amarin", "Is Amarin a $20 Billion Stock?", "Why Amarin Stock Is Jumping Today", "Better Buy: Gilead Sciences vs. Amgen", "Are These Biotech Companies Buyout Candidates? Deal Or No Deal?", "Amarin's Vascepa Gets FDA Approval For Expanded Use, Shares Up 5%", "Amarin Has the Makings for a Gamechanging Product", "3 Biotech Stocks That Can Double Your Money in 2020", "Amarin\u2019s Vascepa Approval Seems Fishy for Patients and AMRN Investors", "Amarin Stock Has Lower Risk, But How Much Reward?", "2 Top Biotech Buyout Candidates", "All Eyes on These 3 Biotech Stocks Ahead of FDA Decisions", "4 FDA Dates Biotech Investors Should Circle in December", "3 Biotechs Facing FDA Approvals by Year's End", "Biotech\u2019s Year-End To-Do List", "Acquisition Rumors Aren\u2019t the Only Thing Moving Amarin Stock", "Amarin Stock Has Lower Risk, But How Much Reward?", "For Now, Amarin Stock Is a Gamble on FDA Approval", "Biotech Stocks Facing FDA Decision In December 2019", "Should You Sell or Hold a Stock after a 6X Gain in Two Days?", "Interesting AMRN Put And Call Options For January 2020", "2 Top Biotech Stocks to Buy Right Now", "Why Did Farallon Capital Get Out of These 3 Biotech Stocks?", "PPH's Holdings Imply 12% Gain Potential", "January 2020 Options Now Available For Amarin (AMRN)", "Is Amarin's Fish Oil Pill on Track to Become a Blockbuster?", "Is Amarin Really a $7 Stock?", "3 Top Healthcare Stocks to Buy in November", "Here's Why Amarin Dropped as Much as 16.0% Today", "Hedge Fund Innovator Joseph Edelman Doubles Down on These 3 Biotech Stocks", "Looking for a Biotech Stock That's an Ideal Buyout Candidate? This Is It.", "Oppenheimer Sees Doom and Gloom in Amarin (AMRN) Stock", "Does Amarin Have a Dark Horse Suitor?", "Why the Rally in Amarin Stock Should Hold Strong", "The Question is Not Why Amarin Stock May Go Up, But Should It?", "Health Care Sector Update for 11/15/2019: PSTV,TARO,AMRN,TORC", "Health Care Sector Update for 11/15/2019: TARO,AMRN,TORC", "Health Care Sector Update for 11/15/2019: TORC, AGRX, AMRN, JNJ, PFE, ABT, MRK, AMGN", "What's Next for Amarin's Stock?", "Amarin's Stock Could Reach $50 Per Share Soon", "How Much Higher Can Amarin (AMRN) Stock Go Following FDA Approval?", "Why Amarin, Ladenburg Thalmann Financial Services, and PG&E Jumped Today", "5 Top Stock Trades for Wednesday: SPY, DIS, PYPL", "Why Amarin Stock Is Crushing It Today", "20 Stocks That Could Double Your Money in 2020", "There\u2019s an Opportunity Brewing in Amarin (AMRN) Stock Ahead of Vascepa\u2019s AdCom, Says Analyst", "December 27th Options Now Available For Amarin (AMRN)", "Is Amarin a Buy?", "Today's Top 5 Gainers In Healthcare Sector (AMRN, DMAC, TNXP...)", "Is Amarin a Buy After a Strong Q3?", "Amarin Corporation plc (AMRN) Q3 2019 Earnings Call Transcript", "December 13th Options Now Available For Amarin (AMRN)", "Biotech Stocks Facing FDA Decision In November 2019", "December 6th Options Now Available For Amarin (AMRN)", "5 Strong Buy Biotech Stocks With Rapidly Approaching Catalysts", "7 Stocks to Buy With 100% Upside Potential", "6 Reasons Investors Are Nervous About Amarin's Big Date With the FDA", "Why Amarin Investors Have Their Eyes on Nov. 14", "Will The Pace of M&A Pick Up Following The Biotech Sector\u2019s Pounding?", "AMRN November 29th Options Begin Trading", "5 Top Stock Trades for Thursday: IRBT, AMRN, CGC", "3 Mid-Cap Biotech Stocks To Consider Buying Now", "Amarin Becomes Oversold (AMRN)", "How Fishy Is This Fish Oil Pill?", "2 Stocks That Could Double Your Money in 2020", "Why the Healthcare Revolution Should Make You Rethink When You'll Claim Social Security", "Health Care Sector Update for 09/16/2019: AMRN,TSLA,ALDR,ACB,ACB.TO", "Why Amarin Stock Dropped 19% in August", "Amarin: Keep Your Dry Powder Ready", "3 Top Healthcare Stocks to Buy Right Now", "8 Biotech Stocks to Watch After the Q2 Earnings Season", "Amarin Becomes Oversold (AMRN)", "3 Top Biotech Stocks to Buy Right Now", "How the 10 Best Stocks From Last Year Hold Up Today", "Why Amarin Stock Is Tanking Today", "Health Care Sector Update for 08/09/2019: AMRN,NVRO,NKTR", "Health Care Sector Update for 08/09/2019: VRAY, NKTR, AMRN, JNJ, PFE, ABT, MRK, AMGN", "FDA To Hold Advisory Committee Hearing For Amarin's Vascepa SNDA, Stock Fall 22%", "What You'll Want to Know About Amarin's Strong Q2 Results", "November 15th Options Now Available For Amarin (AMRN)", "3 Takeaways From Amarin's Earnings", "Health Care Sector Update for 07/31/2019: HUM, TTOO, AMRN, JNJ, PFE, ABT, MRK, AMGN", "Amarin: Is a Buyout Really Off the Table?", "Notable Two Hundred Day Moving Average Cross - AMRN", "Why United Rentals, Eagle Bancorp, and Amarin Slumped Today", "Here's Why Amarin Stock Tumbled Today", "2 Incredibly Cheap Biotech Stocks to Buy Now", "Amarin Corporation plc (AMRN) Q2 2019 Earnings Call Transcript", "3 Big Stock Charts for Wednesday: CVS Health, Pfizer and Weyerhaeuser", "Why Maxar Technologies, Amarin, and Revolve Group Jumped Today", "Here's Why Amarin Rose as Much as 16.3% Today", "5 Top Stock Trades for Wednesday: NKE, AMRN, GS", "Health Care Sector Update for 07/02/2019: WMGI,CUR,AMRN,NTGN", "Mid-Afternoon Market Update: Acuity Brands Falls On Downbeat Sales; Amarin Shares Jump", "Health Care Sector Update for 07/02/2019: CUR,AMRN,NTGN", "Why Amarin Stock Is Up 63% So Far in 2019", "Health Care Sector Update for 07/02/2019: AMRN, CUR, IOVA, JNJ, PFE, ABT, MRK, AMGN", "2 Stocks That Could Be the Next Biotech Buyouts", "5 Top Stock Trades for Friday: AAPL, VEEV, DG, DLTR", "3 Top Mid-Cap Stocks to Buy Right Now", "Why Cypress Semiconductor, Amarin, and Heico Jumped Today", "Health Care Sector Update for 05/29/2019: EVH,AMRN,SOLY,MNK", "Health Care Sector Update for 05/29/2019: AMRN,SOLY,MNK", "Amarin News: Why AMRN Stock Is Soaring Today", "Health Care Sector Update for 07/02/2019: AMRN, CUR, IOVA, JNJ, PFE, ABT, MRK, AMGN", "Here's What You Need to Know From Amarin's Q1 Earnings Update", "Amarin Corporation plc (AMRN) Q1 2019 Earnings Call Transcript", "4 More Healthcare Earnings Reports to Watch This Week", "Is Amarin a Buy?", "Amarin (AMRN) Outpaces Stock Market Gains: What You Should Know", "European ADRs Move Lower in Wednesday Trading", "Here's Why Amarin Soared Today", "Friday's ETF Movers: IBB, KRE", "Friday's ETF Movers: IBB, KRE", "Health Care Sector Update for 03/28/2019: TCDA,OSMT,AMRN,CTST", "Amarin News: Why AMRN Stock Is Surging Today", "Health Care Sector Update for 03/28/2019: OSMT,AMRN,CTST", "European ADRs Move Lower in Thursday Trading", "Health Care Sector Update for 03/28/2019: CTST, AMRN, VLRX, JNJ, PFE, ABT, MRK, AMGN", "Amarin (AMRN) Outpaces Stock Market Gains: What You Should Know", "Health Care Sector Update for 03/28/2019: TCDA,OSMT,AMRN,CTST", "Amarin News: Why AMRN Stock Is Surging Today", "Health Care Sector Update for 03/28/2019: OSMT,AMRN,CTST", "Is Amarin a No-Brainer Stock to Buy on the Dip?", "Here's Why Amarin Gained 17% in February", "Health Care Sector Update for 03/05/2019: PMD,ACB,ACB.TO,AMRN,ADMS", "Health Care Sector Update for 03/05/2019: AMRN,ACB,ACB.TO,ADMS", "Pre-Market Most Active for Mar 28, 2019 : SHV, QQQ, DB, QTNA, SQQQ, NOK, AMRN, AMD, SAN, NIO, CTST, ACB", "Amarin (AMRN) Misses Earnings & Beats Revenues in Q4", "Amarin Corporation plc (AMRN) Q4 2018 Earnings Conference Call Transcript", "Pre-Market Earnings Report for February 27, 2019 : LOW, AMT, TJX, PEG, BBY, AES, CPB, IONS, AMRN, UTHR, LIVN, HPT", "How The Parts Add Up: ADRU Targets $23", "7 Top Analyst Stock Buys", "What's in the Cards for Amarin (AMRN) This Earnings Season?", "2 Healthcare Stocks Ripe for a Takeover", "Is Amarin Sitting on a Goldmine?", "Amarin (AMRN) Gains As Market Dips: What You Should Know", "Why Amarin Stock Jumped 29% in January After Soaring 239% Last Year", "The Biggest Biotech Binary Event in 2019 Is Just Around the Corner", "Why Short-Sellers Raised Their Bets Against 2 Surging Biotech Stocks", "Do Options Traders Know Something About Amarin (AMRN) Stock We Don't?", "3 Stocks That Are Absurdly Cheap Right Now", "ADRU's Underlying Holdings Could Mean 16% Gain Potential", "7 Strong Buy Stocks With Over 20% Upside", "Would Pfizer Shareholders Win With an Acquisition of Amarin?", "Why Amarin Stock Skyrocketed 239% in 2018 -- and Is Up 26% in 2019", "3 Biotech Stocks That Soared This Week: Are They Buys?", "Amarin (AMRN) Stock Up on Rumors of Acquisition by Pfizer", "Why Aurora Cannabis, Amarin, and Constellation Brands Jumped Today", "Health Care Sector Update for 01/10/2019: AMRN,PFE,HALO,PRPO,CGIX", "Thursday's ETF with Unusual Volume: ADRD", "3 Biotech Stocks That Could Be Slapped by the U.S. Government Shutdown", "Amarin Down on Lower '19 View, Posts Preliminary '18 Results", "2 Healthcare Stocks to Buy This Week", "The Top Healthcare Stocks of 2018: Can They Continue in 2019?", "These 3 Stocks Turned $1,000 Into $7,000 -- in Just 1 Year!", "3 Biotech Stocks That Are Too Cheap to Ignore", "Amarin (AMRN) Gains As Market Dips: What You Should Know", "Biotech Stocks Made Big Progress Toward Preventing Heart Attacks in 2018", "Amarin Corporation's Stock Heats Up on Buyout Chatter", "7 Hot Stocks to Buy in a Cold Market", "Here's Why Amarin Fell 13.6% in November", "Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock?", "5 Stocks to Buy and Put Under Your Christmas Tree", "Amarin (AMRN) Stock Sinks As Market Gains: What You Should Know", "2 Biotech Stocks Poised for Big Gains in 2019", "Serious Questions Surround CV Sciences Stock", "Implied ADRU Analyst Target Price: $24", "Why U.S. Steel, Amarin, and Papa John's International Slumped Today", "Why Amarin's Latest News Caused Shares to Crash 13% Today", "Pre-Market Most Active for Nov 15, 2018 : AGNC, BCS, QQQ, CME, ACWI, WMT, AMD, AMRN, ED, BABA, NIO, KREF", "Why Is Amarin Corporation Stock Up 300% in 2018?", "Why Amarin Corporation's Stock Is on the Mend Today", "Wednesday\u2019s Vital Data: Macy\u2019s, Amarin and Starbucks", "3 Stock Charts for Wednesday: Home Depot, PPL and HollyFrontier", "Pre-Market Most Active for Nov 27, 2018 : SQQQ, AAPL, QQQ, AMD, AMRN, ASX, TVIX, IBN, STM, NOK, NIO, KOS", "Pre-Market Most Active for Nov 14, 2018 : BHGE, CHK, TAHO, VICI, LYG, M, AMRN, QQQ, AMD, SQQQ, AAPL, TQQQ", "Amarin's Vascepa Cuts Heart Risk in Outcomes Test, Stock Down", "Why Halliburton, Tyson Foods, and Amarin Slumped Today", "Here's Why Amarin Corporation Tumbled 20% Today", "Why Amarin Corporation's Stock Is Falling Today", "Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock?", "Pre-Market Most Active for Nov 12, 2018 : AMRN, QQQ, APTI, AAPL, AMD, SQQQ", "Peek Under The Hood: ADRU Has 19% Upside", "Pre-Market Most Active for Nov 14, 2018 : BHGE, CHK, TAHO, VICI, LYG, M, AMRN, QQQ, AMD, SQQQ, AAPL, TQQQ", "Amarin's Vascepa Cuts Heart Risk in Outcomes Test, Stock Down", "Why Halliburton, Tyson Foods, and Amarin Slumped Today", "Amarin (AMRN) Beats Earnings & Misses Revenues in Q3", "Amarin (AMRN) Gains As Market Dips: What You Should Know", "Why Investors Are Paying a Premium for These 3 Biotech Stocks", "Amarin (AMRN) Dips More Than Broader Markets: What You Should Know", "Tuesday\u2019s Vital Data: Activision, Amarin and Apple", "4 Strong Stocks to Buy That Double As Big Takeover Targets", "Pre-Market Most Active for Oct 12, 2018 : QQQ, SQQQ, CORI, BABA, SNAP, SQ, BAC, AAPL, TQQQ, AMRN, NIO, JPM", "Is Amarin Corporation PLC a Buy?", "2 Biotech Stocks On A Winning Streak", "Amarin (AMRN) Stock Moves -1.51%: What You Should Know", "Why Amarin Stock Skyrocketed 415% in September", "Pre-Market Most Active for Oct 5, 2018 : VTVT, QQQ, PBR, SNAP, GPRO, AMRN, TSLA, TVIX, ABX, CS, CHK, SAN", "Up 314% in One Day ... and Then Another 58%: How to Find the Next Amarin", "4 Strong Stocks to Buy That Double As Big Takeover Targets", "Pre-Market Most Active for Oct 12, 2018 : QQQ, SQQQ, CORI, BABA, SNAP, SQ, BAC, AAPL, TQQQ, AMRN, NIO, JPM", "5 Top Healthcare Mutual Funds to Buy in October", "2 Healthcare Stocks That Soared in September: Can They Keep Climbing?", "Financial Exchange Stock Talk: Joe McCann On Amarin", "5 Best Biotech Stocks to Buy In October", "Pre-Market Most Active for Oct 1, 2018 : GE, TSLA, AMRN, F, SQQQ, QQQ, TLRY, AAPL, BAC, NIO, TEVA, SNY", "3 Stocks to Buy and Hold for Decades", "Healthcare: 2 Hot Biotech Stocks on Our Radar", "Why Bojangles, Lions Gate Entertainment, and Amarin Jumped Today", "Why Amarin Is Rallying Over 10% (Again!) on Friday", "Amarin's Stock Soars as Fish Oil Drug Lowers Heart Risks", "3 Drugmakers Not Pleased With Amarin's Fish Oil Triumph", "Biotech Stock Roundup: ALXN Soliris Successful, Respite For Sarepta, AMRN Soars", "Pre-Market Most Active for Sep 26, 2018 : CNP, GPRO, AZN, QQQ, BCS, SQ, AMRN, NOK, NKE, TLRY, CONE, CRON", "How Big Could Amarin's Vascepa Be?", "Pre-Market Most Active for Sep 25, 2018 : AMRN, SNAP, IBN, DLR, FB, AZN, TLRY, CRON, ABX, BP, QQQ, VSTM", "Biotech News: Why Amarin Stock Is Going Gangbusters Today", "Mid-Morning Market Update: Markets Open Lower; SiriusXM To Buy Pandora For $3.5B", "Is It Time to Ditch Your Fish Oil Pill for This \"Miracle\" Medicine?", "Wall Street Sees Downbeat Session as China Backs Away From Trade Talks", "Pre-Market Most Active for Sep 24, 2018 : AMRN, P, SIRI, TOT, JD, QQQ, SYMC, CMCSA, ABX, NIO, CHK, XON", "Forget Tilray, These Two Biotech Stocks Have Far More Upside", "Tuesday\u2019s Vital Data: General Electric Company, Snap and Amarin", "Why Barrick Gold, Amarin, and California Resources Jumped Today", "After Hours Most Active for Sep 24, 2018 : GE, JNPR, QCOM, FCX, FDC, T, MU, F, FOXA, QQQ, AMRN, INTC", "Health Care Sector Update for 09/24/2018: ANAB,AMRN,XON,TRXC", "Mid-Afternoon Market Update: Crude Oil Up 2%; Astrotech Shares Plunge", "Health Care Sector Update for 09/24/2018: TRXC,AMRN,XON", "US Futures Head South as China Backs Away From Trade Talks", "Why Amarin Corporation Stock Is Exploding Higher Today", "The Big Party in Amarin Stock Is Just Getting Started", "Why Barrick Gold, Amarin, and California Resources Jumped Today", "After Hours Most Active for Sep 24, 2018 : GE, JNPR, QCOM, FCX, FDC, T, MU, F, FOXA, QQQ, AMRN, INTC", "Health Care Sector Update for 09/24/2018: ANAB,AMRN,XON,TRXC", "Mid-Afternoon Market Update: Crude Oil Up 2%; Astrotech Shares Plunge", "Health Care Sector Update for 09/24/2018: TRXC,AMRN,XON", "Will Amarin Reward Patient Investors?", "A New Deal Moves MannKind Back From the Brink", "3 Biotech Stocks That Still Have Major Catalysts in September", "Why Amarin Corporation Skyrocketed 23.9% in August", "3 Biotech Stocks That Could Soar Next Week", "Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock?", "Moving Average Crossover Alert: Amarin (AMRN)", "Health Care Sector Update for 04/04/2018: LLY, AMRN, GSK", "Is Now the Perfect Time to Buy Amarin Corporation Stock?", "Why Amarin Corporation Zoomed 10% Higher Today", "Is the Options Market Predicting a Spike in Amarin (AMRN) Stock?", "Health Care Sector Update for 05/02/2018: AMRN,UTHR,ZTS", "3 Stocks That Could Put Tesla's Returns to Shame", "Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock?", "Moving Average Crossover Alert: Amarin (AMRN)", "Health Care Sector Update for 04/04/2018: LLY, AMRN, GSK", "Is Now the Perfect Time to Buy Amarin Corporation Stock?", "Health Care Sector Update for 04/04/2018: SNN,AMRN,GSK,LLY", "Health Care Sector Update for 04/04/2018: AMRN,GSK,LLY", "Implied Volatility Surging for Amarin (AMRN) Stock Options", "3 Stocks That Could Put Alibaba's Returns to Shame", "Implied Volatility Surging for Amarin (AMRN) Stock Options", "Health Care Sector Update for 02/27/2018: MNK, IART, AMRN, PRGO. EXEL", "Health Care Sector Update for 02/27/2018: IART,PRGO,MNK,AMRN", "Boom-or-Bust News Is On Tap Soon for Amarin", "Health Care Sector Update for 01/30/2018: AMRN,IMMY,CRBP,ALDR,BRK.A,BRK.B,AMZN,JPM", "The Implied Analyst 12-Month Target For ADRU", "Amarin (AMRN) Soars: Stock Adds 9.9% in Session", "Why Amarin Corporation Stock Is Surging Today", "Wall Street Wavers as Congress Ends Government Shutdown", "Health Care Sector Update for 01/23/2018: JNJ, PFE, ABT, MRK, AMGN, TNXP, VYGR, BLRX, AMGN, CELG", "Pre-Market Most Active for Jan 23, 2018 : VZ, NFLX, VALE, QQQ, ITUB, CHK, HSBC, SAN, AMRN, TVIX, FOX, GPRO", "Health Care Sector Update for 02/27/2018: PRGO,MNK,AMRN", "Amarin Corporation (AMRN) in Focus: Stock Moves 8.9% Higher", "3 Growth Stocks to Own in 2018", "10 Cheap Stocks to Buy With Only $12", "European ADRs Edge Higher as Banks Head North", "3 Small-Cap Biotech Stocks That Could Be Big Winners in 2018", "Tech Bounces Back", "Are Options Traders Betting on a Big Move in Amarin (AMRN) Stock?", "Here's Why Amarin Corporation plc Is on the Rise Today", "Here's Why Amarin Corporation plc Surged 34% Higher in June", "Is the Options Market Predicting a Spike in Amarin (AMRN) Stock?", "4 Biotech Stocks With Jaw-Dropping Growth Potential", "Here's What Pushed Amarin Corporation plc 15% Higher in February", "European ADRs Edge Higher as Banks Advance", "European ADRs Edge Lower as Manufacturers Head South", "Overseas Earnings Estimated to Outdo US: Top 5 Gainers", "European ADRs Edge Higher as Pharmaceutical Stocks See Mixed Fortunes", "3 Stocks the Smartest Investors Are Buying Right Now", "3 Stocks That Could Make You Rich", "4 Biotech Stocks With Jaw-Dropping Growth Potential", "3 Small-Cap Biotech Stocks on the Rise in 2017", "7 Underdog Stocks We're Watching Closely", "Penny Stocks: 2 to Buy, 2 to Avoid", "More Innovation, Less Regulation: 2 Biotech Stocks That Could Soar in 2017", "1 Reason Amarin's Stock Skyrocketed in 2016", "Ocera Therapeutics (OCRX) Catches Eye: Stock Jumps 6.8%", "European ADRs Edge Lower as Pharma Stocks See Mixed Fortunes", "Amarin's Stock Buckled in October. Is It Now a Bargain?", "3 Important Things You Need to Know About Amarin's Q3 Results", "European ADRs Edge Lower as Pharma Stocks Post Mixed Fortunes", "European ADRs Edge Higher as Financial Services Stocks Post Gains", "Patterson Companies (PDCO) Q2 Earnings: What's in Store?", "Teva Trisenox Wins CHMP Nod for Expanded Use in Leukemia", "Tetraphase Begins Phase III Dosing of Antibiotic Candidate", "Allergan's Belkyra Gets Swedish Approval for Double Chin", "Sunesis Submits Response to Questions on Leukemia Drug", "OncoGenex Cancer Drug Fails in Phase III Study, Stock Down", "Intellia Therapeutics (NTLA) Looks Good: Stock Gains 9.9%", "AMAG Issues Encouraging Updates on Makena & Feraheme", "AstraZeneca's Hyperkalemia Drug NDA Resubmission Accepted", "5 Small-Cap Stocks to Buy in October", "Will Amarin (AMRN) Continue to Surge Higher?", "Amarin Corporation (AMRN) Looks Good: Stock Adds 6.1% in Session", "Biotech Stocks Under $5: 2 to Buy, 1 to Avoid", "European ADRs Fractionally Higher as Pharma Stocks Rally", "European ADRs Marginally Lower as Telecom Stocks and Banks Retreat", "Allergan Gets Priority Review for Avycaz Label Expansion", "European ADRs Edge Higher as Printer Manufacturers Post Gains", "Zacks.com featured highlights: Amarin, Compugen, Raptor Pharmaceuticals, ArcelorMittal and Hovnanian Enterprises", "Forget Gilead Sciences Inc.: These 3 Stocks Are Better Buys", "Explosive Stocks Under $10", "Amarin (AMRN) Ends Patient Randomization in Vascepa Study", "Is Amarin Corporation Stock a Solid Choice Right Now?", "Mid-Day Market Update: Dow Surges Over 100 Points; Caesars Entertainment Shares Slide", "Why Polaris Industries, Amarin, and VimpelCom Slumped Today", "After Hours Most Active for Aug 12, 2016 : AMRN, BAC, FTR, TEVA, EXC, QQQ, VER, SDRL, AVP, SYMC, MSFT, MYL", "Pre-Market Most Active for Aug 11, 2016 : CLF, BABA, VRX, BRX, M, NRZ, YHOO, MXIM, AMRN, XIV, NFLX, DNKN", "Why Shake Shack, Amarin, and Valeant Pharmaceuticals Slumped Today", "Pre-Market Most Active for Aug 4, 2016 : NOK, CHK, AZN, SQ, CP, FOXA, BAC, GOLD, AAPL, ALIM, AMRN, XIV", "Health Care Sector Update for 08/04/2016: JNJ, PFE, ABT, MRK, AMGN, AMRN, SGMO", "Mid-Morning Market Update: Markets Mostly Higher; Tesla To Acquire SolarCity", "Mid-Afternoon Market Update: Trina Solar Gains Following Go-Private Deal; Insperity Shares Drop", "After Hours Most Active for Aug 22, 2016 : ABBV, CSCO, XOM, LDOS, AMRN, SYF, BSM, SYMC, OAS, TLT, QQQ, AMAT", "European ADRs Extend Gains as Manufacturers Advance", "3 Risky Biotech Stocks That Could Make You Rich", "European ADRs Extend Gains as Pharma Stocks Surge", "This Tiny Biopharma Has Been Bucking The Downtrend", "Amarin (AMRN) Looks Good: Stock Adds 6.7% in Session", "Why Amarin, Marketo, and Westar Energy Jumped Today", "2 Biotech Stocks Under $5 With Jaw-Dropping Growth Potential", "European ADRs Edge Higher as Banking Stocks Log Gains", "European ADRs Edge Lower as Manufacturing Stocks Post Contractions", "European ADRs Edge Lower as Pharma Stocks Retreat", "European ADRs Marginally Higher as Pharma Stocks See Mixed Fortunes", "European ADRs Edge Higher in Thursday Trading", "3 Biotech Stocks With Scary-High Debt-to-Capital Ratios", "European ADRs Edge Higher as Semiconductor, Pharma Stocks See Mixed Fortunes", "European ADRs Edge Lower as Commodities Stocks Retreat", "European ADRs Modestly Higher as Pharma Gains Offset Mining Losses", "Health Care Sector Update for 03/09/2016: AMRN,ADRO,STEM", "European ADRs Rise as Italian Furniture Manufacturer Natuzzi Surges 8 Per Cent", "European ADRs Edge Up as Telecommunication Stocks See Mixed Fortunes", "3 Reasons Behind Amarin's Strong 2015", "European ADRs Slip Lower as Pharmaceutical Stocks Drive Moves", "Wednesday's ETF with Unusual Volume: GWX", "European ADRs Advance as Industrial Products Manufacturers Gain", "7 Top Stocks to Buy in March", "European ADRs Lower as Education Company Pearson Sees Shares Slump", "European ADRs Marginally Higher as Oil and Gas Production Companies Advance", "European ADRs Trade at Two Year Low as Miners Contract", "European ADRs Log Marginal Gains as Pharma Stocks See Mixed Fortunes", "3 Battleground Biotech Stocks I Would Avoid at All Costs", "European ADRs Advance as Mining Stocks Extend Rally", "European ADRs Lower as Pharma Losses Fail to Offset Mining Rally", "10 Cheap Stocks Under $10 to Buy for 2016", "European ADRs Trade Higher as Health Care Companies Advance", "European ADRs Retreat as Miners Pull Back", "European ADR Slide as Oil Stocks Edge Lower", "European ADRs Make Modest Gains as Mining Losses Partially Offset Higher Oil Stocks", "3 Things You Should Know About Amarin Plc", "European ADRs Trade Lower as Financial Services Stocks Slide", "European ADRs Ebb as Pharma Stocks Contract", "Why Amarin Corporation plc (ADR) is Moving Higher Today", "European ADRs Slide as Banking Stocks Trade Lower", "3 Biotech Stocks That I Won't Buy", "European ADRs Trade Lower as Pharma Stocks Slide", "Amarin Corporation PLC Shares Lifted Off in May -- Here's Why", "European ADRs Trade Lower as Oil Stocks Feel the Pinch", "European ADRs Fall Lower as Pharma Stocks Dominate Trading", "Amarin (AMRN) in Focus: Stock Surges 19% in Session - Tale of the Tape", "European ADRs Gain Traction as Retail Stocks Surge", "Why Shares in Amarin Corporation Plc Are Soaring", "Why Amarin Corporation (AMRN) Could Be Positioned for a Slump - Tale of the Tape", "Which of These Growth Stocks Is Most Worthy of Your Money?", "European ADRs Fractionally Higher as Pharmaceuticals Stocks Gain", "In Case You Missed It, This New Study Suggests America Is a Nation of Couch Potatoes", "European ADRs Contract as Tech Stock Losses Weigh", "European ADRs Trading Lower Despite Mining Gains", "Is Amarin Corporation Plc Stock About to Double?", "How Amarin Corporation (AMRN) Stock Stands Out in a Strong Industry - Tale of the Tape", "Here's the Lowdown on Amarin Corporation PLCs 55% Move Higher in March", "3 Biotech Stocks in Danger of Running Out of Cash", "European ADRs Flat as Pharma Gains Are Outweighed By Mining Losses", "Should Investors Toss in the Towel on Amarin Corp Plc?", "European ADRs Higher as Eurozone Growth Gathers Pace", "Biotech Stocks: 2 to Avoid, 1 to Buy", "Why Amarin Corp Plc Slumped Today", "European ADRs Gain as Pharma Stocks Pick Up Momentum", "Why Amarin Corporation Plc Burst Today", "European ADRs Lower as Telecom Companies Slide", "After Hours Most Active for Mar 17, 2015 : HSIC, AMRN, ORCL, FITB, F, PBR, BWLD, BAC, UTX, ADBE, PBR/A, AAPL", "European ADRs Start the Week Higher; Pharma Stocks Gain", "Pre-Market Most Active for Mar 16, 2015 : AMRN, SLXP, TVIX, RDS/B, FXCM, BAC, XIV, QQQ, AAPL, LTM, MT, NOK", "After Hours Most Active for Mar 16, 2015 : DHR, JD, QQQ, HOT, APC, IBN, DEPO, HTZ, HLT, AMRN, INTC, FTSM", "European ADRs Lower Despite Mixed Results for Oil Stocks", "Pre-Market Most Active for Mar 12, 2015 : BAC, LL, ACAD, HSBC, EQM, CYBR, C, AAPL, QQQ, KO, AMRN, TVIX", "Why Amarin Corporation PLC Soared 48% in February", "Earnings Reaction History: Amarin Corp., 42.9% Follow-Through Indicator, 6.6% Sensitive", "What's in Store for Geron (GERN) this Earnings Season? - Analyst Blog", "Intercept Pharmaceuticals (ICPT): Will It Miss Q4 Earnings? - Analyst Blog", "Will Stratasys (SSYS) Disappoint this Earnings Season? - Analyst Blog", "European ADRs End the Week At Two-and-a-Half Month High", "Why Amarin Corporation plc Blasted Higher", "Will Endo Internationa's (ENDP) Beat on Earnings in Q4? - Analyst Blog", "Will Mylan (MYL) Beat Earnings on New Product Launches? - Analyst Blog", "What Awaits Keryx Biopharmaceuticals (KERX) this Earnings? - Analyst Blog", "Why Amarin Corporation plc Surged Higher Today", "Will Epizyme (EPZM) Miss Estimates This Earnings Season? - Analyst Blog", "Should You Buy Amarin Corporation (AMRN) Ahead of Earnings? - Tale of the Tape", "What's in Store for OmniVision (OVTI) This Earnings? - Analyst Blog", "Will Arena Pharmaceuticals (ARNA) Disappoint on Q4 Earnings? - Analyst Blog", "Will Aegerion (AEGR) Miss Earnings Estimates This Season? - Analyst Blog", "Will Ingram Micro (IM) Miss Earnings Estimates in Q4? - Analyst Blog", "Can The Uptrend Continue for Amarin (AMRN)? - Tale of the Tape", "European ADRs Higher Mid-Week; Mixed Performance for Pharma Stocks", "Why Amarin Corporation Shares Are Sky-rocketing", "European ADRs Lifted by Pharmaceutical Stock Gains", "Why Amarin Corporation PLC Stock Flew 37% Higher in November", "Merrimack Pharmaceuticals (MACK): A Miss this Earnings? - Analyst Blog", "Amarin Plunges after the FDA Denies Vascepa SPA Appeal - Analyst Blog", "Markets Drop; Darden Adjusted Profit Beats Street View", "Why Amarin Corporation plc Stock Cratered", "US Stocks Poised For Lower Open Amid Larger Than Expected Drop in Export Prices; Retail Rise Meets Views", "Dow Falls Over 100 Points; Ulta Salon Shares Jump After Earnings Report", "Conversant Shares Rise On Acquisition News; Health Care REIT Drops", "European ADRs Pulled down by Contractions in Pharmaceutical Stocks", "Amarin Corporation plc (AMRN) in Focus: Stock Soars 23.4% - Tale of the Tape", "Biotech Investing: 3 Ways You're Doing It Wrong", "Noteworthy option trades in equities", "Shire Retreats for Second Day Since Abbvie's Revised Bid as European ADRs Decline; Portugal Telecom Gains", "European ADRs Post Broad Declines After European Markets Weaken on German, U.K. Economic Data", "Amarin Leads Gains in European ADRs After Favorable Journal Article; Nokia Down on Amazon.com Phone", "European ADRs Show Broad Declines After Region's Markets Pressured by", "Ligand-AstraZeneca Collaborate - Analyst Blog", "Corrected: European ADRs Higher on Banking Gains", "Largest option trades in equities", "Sector Update: Healthcare Shares Flat in Pre-Market Trade; Amarin Partners with Kowa to Promote Vascepa", "Sector Update: Healthcares", "Amarin's Vascepa Gets 3-Year Exclusivity - Analyst Blog", "Amarin Tumbles after DMEP Decision - Analyst Blog", "Biotech Stock Roundup: Sarepta Spikes on Data & Alnylam on Deal - Analyst Blog", "Pre-Market Most Active for Jan 16, 2014 : BBY, BAC, C, BHP, JCP, FOX, RESI, SRPT, FB, AMRN, MU, DRYS", "Earnings Reaction History: Amarin Corp., 57.1% Follow-Through Indicator, 6.9% Sensitive", "Update on Amarin's Vascepa - Analyst Blog", "Sector Update: Healthcare Shares Mixed Pre-Market; Amarin Soars 15% on Labeling Expansion Process", "Sector Update: Healthcare", "Mid-Day Market Update: SanDisk Surges On Upbeat Results; IBM Shares Tumble", "Sector Update: Healthcare Stocks Lower; United Health Down 3% on Quarterly Results", "Sector Update: Healthcare", "Pre-Market Most Active for Oct 17, 2013 : AMRN, SVU, BAC, PACT, FB, AUO, SMFG, EBAY, NOK, IBM, QQQ, VOD", "After Hours Most Active for Jan 15, 2014 : C, JPM, WFC, F, BAC, MET, QQQ, MSFT, MU, SIRI, AMRN, SPIL", "Pre-Market Most Active for Oct 14, 2013 : BAC, ALU, FB, AMD, SIRI, QQQ, MU, VOD, GFI, HMY, AMRN, PHG", "Heatlhcare Stock Moderately Higher Near Close; Amarin Slumps After FDA Questions Trial Procedures", "Sector Update: Healthcare", "Biotech Stocks Continue Recent Downtrend; Ariad Tumbles to Lowest Price in Nearly Three Years", "Update on Amarin Study - Analyst Blog", "Sector Update: Healthcare Stocks Flat in Pre-Market; Syngeva Prices Public Offering", "Sector Update: Healthcare", "FDA Not in Favor of Amarin's Vascepa - Analyst Blog", "Amarin Corporation (AMRN) in Focus: Stock Moves Higher by 8% - Analyst Blog", "Can the Recent Uptrend Continue for Amarin Corporation plc (AMRN)? - Tale of the Tape", "Positive Data on MannKind's Afrezza - Analyst Blog", "Wider-than-Expected Loss at MannKind - Analyst Blog", "Pre-Market Most Active for Jul 9, 2013 : SIRI, BP, AA, APU, BAC, NOK, AMRN, KNDI, HTSI, SPIL, DELL, CONE", "Benzinga Market Primer: Tuesday, July 9: China Inflation Better Than Expected", "Amarin Offers American Depositary Shares - Analyst Blog", "Largest option trades in equities", "Sector Update: Healthcare", "Pre-Market Most Active for May 30, 2013 : NVE, CLWR, S, MTU, FB, BAC, NJ, EMC, VNR, QQQ, AMRN, FSLR", "Largest option buying in equities so far", "Amarin's Performance Issues: Here To Stay?", "Bulls taking another shot at Amarin", "Dow Muscles Higher Again: Next Stop, 14,000", "How one large bull is playing Amarin", "Sector Update: Healthcare Shares Higher in Pre-Market; Amarin Up 3% on Vascepa Trial Results", "Weekly Guru Bargains Highlights: PANL, THRX, ZNGA, LORL, AMRN", "Pre-Market Most Active for Dec 7, 2012 : BAC, QQQ, NOK, AMRN, VNTV, AVGO, MEMP, AAPL, FB, SAN, C, FCX", "After Hours Most Active for Dec 6, 2012 : MMR, BX, QQQ, S, AMRN, EPHC, BAC, EMC, AIG, DISH, LINTA, ORCL", "Upcoming BioPharma Catalyst Trades to Consider", "Pre-Market Most Active for Oct 24, 2012 : FB, SIRI, EMC, BAC, QQQ, GILD, DOW, ZNGA, MM, BP, SEH, AMRN", "Largest option buying in equities so far", "Trader has bullish formula for Amarin", "AMRN Aims to Fortify Vascepa Patent - Analyst Blog", "Why investor wants to be rid of Amarin", "Largest option buying in equities so far", "Pre-Market Most Active for Jul 27, 2012 : FB, SIRI, AMRN, AUTH, BAC, GDOT, NOK, S, ARMH, SBUX, ACI, NXY", "Bearish trade targets Amarin after rally", "After Hours Most Active for Jul 12, 2012 : QQQ, BAC, AA, WM, TWTC, AMD, AOL, NLY, WIN, MSFT, ATVI, AMRN", "Pre-Market Most Active for Jun 27, 2012 : ERIC, AMRN, BAC, FB, ABB, JNJ, TKC, NOK, OMER, ARNA, NVO, ZNGA", "Pre-Market Most Active for May 29, 2012 : VRTX, BAC, NOK, LCRY, FB, GNOM, STD, BHP, GRFS, AMRN, BUD, C", "Pre-Market Most Active for Sep 11, 2012 : AIG, NOK, BP, SAN, ING, BAC, AAPL, AMRN, GMCR, FB, QQQ, FSC", "Why investor wants to be rid of Amarin", "Top Goldman Sachs Analyst: Sovereign Risk is Spreading Like Wildfire", "Mid-Day Update: Stocks Sitting Higher in Black Friday Rally; Europe Concern Lingers", "Largest option buying in equities so far", "Centenarians: Health Services Stocks With Hedge Fund Buying", "Amarin spread sees good prognosis", "Playing the range: Short strangles", "Volatility play sees Amarin settling down", "Sellers see calmer times for Amarin"], "Elapsed Time": ["1 DAY AGO", "JUN 18, 2020", "JUN 17, 2020", "JUN 17, 2020", "JUN 16, 2020", "JUN 16, 2020", "JUN 11, 2020", "JUN 4, 2020", "1 DAY AGO", "MAY 28, 2020", "MAY 22, 2020", "MAY 22, 2020", "MAY 22, 2020", "MAY 22, 2020", "MAY 22, 2020", "MAY 19, 2020", "MAY 28, 2020", "MAY 9, 2020", "MAY 5, 2020", "MAY 4, 2020", "APR 30, 2020", "APR 30, 2020", "APR 30, 2020", "APR 27, 2020", "MAY 15, 2020", "APR 18, 2020", "APR 15, 2020", "APR 14, 2020", "APR 13, 2020", "APR 13, 2020", "APR 8, 2020", "APR 6, 2020", "APR 19, 2020", "APR 5, 2020", "APR 4, 2020", "APR 2, 2020", "APR 2, 2020", "APR 2, 2020", "APR 1, 2020", "APR 1, 2020", "APR 6, 2020", "MAR 31, 2020", "MAR 31, 2020", "MAR 31, 2020", "MAR 30, 2020", "MAR 24, 2020", "MAR 20, 2020", "MAR 19, 2020", "MAR 31, 2020", "MAR 17, 2020", "MAR 16, 2020", "MAR 10, 2020", "MAR 9, 2020", "MAR 6, 2020", "MAR 6, 2020", "MAR 6, 2020", "MAR 19, 2020", "MAR 3, 2020", "MAR 3, 2020", "MAR 3, 2020", "FEB 28, 2020", "FEB 28, 2020", "FEB 27, 2020", "FEB 26, 2020", "MAR 5, 2020", "FEB 26, 2020", "FEB 26, 2020", "FEB 26, 2020", "FEB 26, 2020", "FEB 25, 2020", "FEB 24, 2020", "FEB 19, 2020", "FEB 26, 2020", "FEB 17, 2020", "FEB 14, 2020", "FEB 14, 2020", "FEB 13, 2020", "FEB 12, 2020", "FEB 12, 2020", "FEB 6, 2020", "FEB 19, 2020", "FEB 4, 2020", "FEB 4, 2020", "JAN 29, 2020", "JAN 28, 2020", "JAN 28, 2020", "JAN 27, 2020", "JAN 27, 2020", "FEB 6, 2020", "JAN 23, 2020", "JAN 23, 2020", "JAN 23, 2020", "JAN 22, 2020", "JAN 22, 2020", "JAN 21, 2020", "JAN 17, 2020", "JAN 27, 2020", "JAN 14, 2020", "JAN 13, 2020", "JAN 13, 2020", "JAN 13, 2020", "JAN 11, 2020", "JAN 10, 2020", "JAN 10, 2020", "JAN 16, 2020", "JAN 9, 2020", "JAN 9, 2020", "JAN 7, 2020", "JAN 7, 2020", "JAN 7, 2020", "JAN 6, 2020", "JAN 6, 2020", "JAN 10, 2020", "JAN 6, 2020", "JAN 4, 2020", "JAN 2, 2020", "DEC 31, 2019", "DEC 31, 2019", "DEC 31, 2019", "DEC 30, 2019", "JAN 6, 2020", "DEC 23, 2019", "DEC 20, 2019", "DEC 19, 2019", "DEC 18, 2019", "DEC 18, 2019", "DEC 16, 2019", "DEC 16, 2019", "DEC 30, 2019", "DEC 16, 2019", "DEC 16, 2019", "DEC 15, 2019", "DEC 14, 2019", "DEC 13, 2019", "DEC 13, 2019", "DEC 11, 2019", "DEC 16, 2019", "DEC 11, 2019", "DEC 11, 2019", "DEC 9, 2019", "DEC 7, 2019", "DEC 7, 2019", "DEC 7, 2019", "DEC 6, 2019", "DEC 11, 2019", "DEC 4, 2019", "DEC 1, 2019", "NOV 27, 2019", "NOV 27, 2019", "NOV 27, 2019", "NOV 26, 2019", "NOV 25, 2019", "DEC 5, 2019", "NOV 22, 2019", "NOV 21, 2019", "NOV 21, 2019", "NOV 20, 2019", "NOV 20, 2019", "NOV 20, 2019", "NOV 19, 2019", "NOV 24, 2019", "NOV 18, 2019", "NOV 18, 2019", "NOV 15, 2019", "NOV 15, 2019", "NOV 15, 2019", "NOV 15, 2019", "NOV 13, 2019", "NOV 18, 2019", "NOV 12, 2019", "NOV 12, 2019", "NOV 12, 2019", "NOV 11, 2019", "NOV 7, 2019", "NOV 7, 2019", "NOV 7, 2019", "NOV 12, 2019", "NOV 6, 2019", "NOV 5, 2019", "OCT 31, 2019", "OCT 28, 2019", "OCT 24, 2019", "OCT 24, 2019", "OCT 23, 2019", "NOV 7, 2019", "OCT 13, 2019", "OCT 11, 2019", "OCT 11, 2019", "OCT 9, 2019", "OCT 4, 2019", "OCT 3, 2019", "OCT 2, 2019", "OCT 19, 2019", "SEP 29, 2019", "SEP 16, 2019", "SEP 10, 2019", "SEP 9, 2019", "AUG 22, 2019", "AUG 20, 2019", "AUG 12, 2019", "OCT 1, 2019", "AUG 9, 2019", "AUG 9, 2019", "AUG 9, 2019", "AUG 9, 2019", "AUG 8, 2019", "JUL 31, 2019", "AUG 12, 2019", "JUL 31, 2019", "JUL 31, 2019", "JUL 21, 2019", "JUL 19, 2019", "JUL 18, 2019", "JUL 18, 2019", "JUL 15, 2019", "JUL 31, 2019", "JUL 3, 2019", "JUL 2, 2019", "JUL 2, 2019", "JUL 2, 2019", "JUL 2, 2019", "JUL 2, 2019", "JUL 2, 2019", "JUL 10, 2019", "JUL 2, 2019", "JUN 29, 2019", "MAY 30, 2019", "MAY 30, 2019", "MAY 29, 2019", "MAY 29, 2019", "MAY 29, 2019", "JUL 2, 2019", "JUL 2, 2019", "MAY 1, 2019", "MAY 1, 2019", "APR 29, 2019", "APR 21, 2019", "APR 12, 2019", "APR 10, 2019", "MAY 29, 2019", "MAR 29, 2019", "MAR 29, 2019", "MAR 28, 2019", "MAR 28, 2019", "MAR 28, 2019", "MAR 28, 2019", "MAR 28, 2019", "APR 5, 2019", "MAR 28, 2019", "MAR 28, 2019", "MAR 28, 2019", "MAR 14, 2019", "MAR 11, 2019", "MAR 5, 2019", "MAR 5, 2019", "MAR 28, 2019", "FEB 27, 2019", "FEB 27, 2019", "FEB 26, 2019", "FEB 25, 2019", "FEB 18, 2019", "FEB 18, 2019", "FEB 17, 2019", "FEB 28, 2019", "FEB 14, 2019", "FEB 4, 2019", "JAN 29, 2019", "JAN 28, 2019", "JAN 24, 2019", "JAN 23, 2019", "JAN 22, 2019", "FEB 15, 2019", "JAN 20, 2019", "JAN 14, 2019", "JAN 12, 2019", "JAN 11, 2019", "JAN 10, 2019", "JAN 10, 2019", "JAN 10, 2019", "JAN 22, 2019", "JAN 7, 2019", "JAN 7, 2019", "JAN 3, 2019", "JAN 2, 2019", "DEC 26, 2018", "DEC 19, 2018", "DEC 18, 2018", "JAN 10, 2019", "DEC 10, 2018", "DEC 10, 2018", "DEC 7, 2018", "DEC 6, 2018", "DEC 3, 2018", "DEC 3, 2018", "NOV 30, 2018", "DEC 18, 2018", "NOV 27, 2018", "NOV 27, 2018", "NOV 15, 2018", "NOV 15, 2018", "NOV 15, 2018", "NOV 14, 2018", "NOV 14, 2018", "NOV 27, 2018", "NOV 14, 2018", "NOV 13, 2018", "NOV 13, 2018", "NOV 13, 2018", "NOV 12, 2018", "NOV 12, 2018", "NOV 12, 2018", "NOV 14, 2018", "NOV 14, 2018", "NOV 13, 2018", "NOV 2, 2018", "NOV 1, 2018", "OCT 26, 2018", "OCT 23, 2018", "OCT 19, 2018", "NOV 6, 2018", "OCT 16, 2018", "OCT 12, 2018", "OCT 12, 2018", "OCT 11, 2018", "OCT 10, 2018", "OCT 9, 2018", "OCT 5, 2018", "OCT 18, 2018", "OCT 16, 2018", "OCT 3, 2018", "OCT 2, 2018", "OCT 2, 2018", "OCT 2, 2018", "OCT 1, 2018", "OCT 1, 2018", "OCT 3, 2018", "SEP 28, 2018", "SEP 28, 2018", "SEP 28, 2018", "SEP 27, 2018", "SEP 26, 2018", "SEP 26, 2018", "SEP 26, 2018", "SEP 30, 2018", "SEP 25, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 25, 2018", "SEP 25, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 24, 2018", "SEP 8, 2018", "SEP 6, 2018", "SEP 5, 2018", "SEP 3, 2018", "SEP 2, 2018", "APR 24, 2018", "APR 12, 2018", "APR 4, 2018", "JUL 11, 2018", "JUN 28, 2018", "MAY 21, 2018", "MAY 2, 2018", "MAY 1, 2018", "APR 24, 2018", "APR 12, 2018", "APR 4, 2018", "JUL 11, 2018", "APR 4, 2018", "APR 4, 2018", "APR 2, 2018", "MAR 20, 2018", "MAR 5, 2018", "FEB 27, 2018", "FEB 27, 2018", "APR 4, 2018", "JAN 30, 2018", "JAN 26, 2018", "JAN 24, 2018", "JAN 23, 2018", "JAN 23, 2018", "JAN 23, 2018", "JAN 23, 2018", "FEB 27, 2018", "DEC 21, 2017", "DEC 18, 2017", "NOV 1, 2017", "OCT 30, 2017", "OCT 19, 2017", "SEP 27, 2017", "AUG 4, 2017", "AUG 2, 2017", "JUL 10, 2017", "MAR 28, 2017", "MAR 21, 2017", "MAR 6, 2017", "MAR 3, 2017", "MAR 2, 2017", "APR 20, 2017", "APR 17, 2017", "APR 7, 2017", "MAR 28, 2017", "MAR 21, 2017", "DEC 14, 2016", "DEC 13, 2016", "NOV 20, 2016", "JAN 11, 2017", "JAN 10, 2017", "DEC 29, 2016", "NOV 8, 2016", "NOV 8, 2016", "NOV 3, 2016", "OCT 28, 2016", "OCT 24, 2016", "NOV 17, 2016", "OCT 18, 2016", "OCT 17, 2016", "OCT 17, 2016", "OCT 14, 2016", "OCT 14, 2016", "OCT 14, 2016", "OCT 13, 2016", "OCT 19, 2016", "OCT 1, 2016", "SEP 29, 2016", "SEP 27, 2016", "SEP 24, 2016", "SEP 20, 2016", "SEP 12, 2016", "OCT 13, 2016", "SEP 7, 2016", "SEP 7, 2016", "SEP 7, 2016", "SEP 6, 2016", "SEP 1, 2016", "AUG 31, 2016", "AUG 29, 2016", "SEP 12, 2016", "AUG 12, 2016", "AUG 11, 2016", "AUG 11, 2016", "AUG 4, 2016", "AUG 4, 2016", "AUG 1, 2016", "AUG 1, 2016", "AUG 22, 2016", "JUL 13, 2016", "JUL 12, 2016", "JUN 28, 2016", "JUN 27, 2016", "JUN 3, 2016", "MAY 31, 2016", "MAY 30, 2016", "JUL 29, 2016", "MAY 6, 2016", "MAY 5, 2016", "MAY 2, 2016", "APR 14, 2016", "APR 11, 2016", "MAR 30, 2016", "MAR 15, 2016", "MAY 9, 2016", "MAR 9, 2016", "MAR 9, 2016", "FEB 16, 2016", "JAN 13, 2016", "DEC 24, 2015", "NOV 25, 2015", "OCT 28, 2015", "MAR 15, 2016", "OCT 21, 2015", "OCT 1, 2015", "SEP 28, 2015", "SEP 2, 2015", "AUG 28, 2015", "AUG 27, 2015", "AUG 20, 2015", "OCT 27, 2015", "JUL 29, 2015", "JUL 24, 2015", "JUL 17, 2015", "JUL 14, 2015", "JUL 11, 2015", "JUL 8, 2015", "JUN 26, 2015", "AUG 7, 2015", "JUN 15, 2015", "JUN 13, 2015", "JUN 9, 2015", "JUN 5, 2015", "JUN 1, 2015", "MAY 29, 2015", "MAY 29, 2015", "JUN 23, 2015", "MAY 28, 2015", "MAY 18, 2015", "MAY 16, 2015", "MAY 4, 2015", "MAY 3, 2015", "APR 30, 2015", "APR 28, 2015", "MAY 29, 2015", "APR 9, 2015", "APR 7, 2015", "APR 2, 2015", "MAR 27, 2015", "MAR 26, 2015", "MAR 24, 2015", "MAR 22, 2015", "APR 28, 2015", "MAR 18, 2015", "MAR 17, 2015", "MAR 17, 2015", "MAR 17, 2015", "MAR 16, 2015", "MAR 16, 2015", "MAR 16, 2015", "MAR 19, 2015", "MAR 12, 2015", "MAR 6, 2015", "MAR 3, 2015", "MAR 2, 2015", "FEB 28, 2015", "FEB 27, 2015", "FEB 27, 2015", "MAR 12, 2015", "FEB 27, 2015", "FEB 27, 2015", "FEB 26, 2015", "FEB 26, 2015", "FEB 25, 2015", "FEB 25, 2015", "FEB 24, 2015", "FEB 27, 2015", "FEB 24, 2015", "FEB 24, 2015", "FEB 23, 2015", "FEB 18, 2015", "FEB 18, 2015", "DEC 24, 2014", "DEC 1, 2014", "FEB 24, 2015", "SEP 15, 2014", "SEP 12, 2014", "SEP 12, 2014", "SEP 12, 2014", "SEP 12, 2014", "SEP 12, 2014", "SEP 11, 2014", "NOV 19, 2014", "AUG 24, 2014", "AUG 18, 2014", "JUL 16, 2014", "JUL 8, 2014", "JUN 19, 2014", "JUN 11, 2014", "MAY 19, 2014", "AUG 25, 2014", "APR 1, 2014", "APR 1, 2014", "APR 1, 2014", "FEB 24, 2014", "JAN 22, 2014", "JAN 22, 2014", "JAN 16, 2014", "MAY 9, 2014", "DEC 27, 2013", "DEC 20, 2013", "DEC 20, 2013", "OCT 17, 2013", "OCT 17, 2013", "OCT 17, 2013", "OCT 17, 2013", "JAN 15, 2014", "OCT 14, 2013", "OCT 11, 2013", "OCT 11, 2013", "OCT 9, 2013", "SEP 26, 2013", "SEP 25, 2013", "SEP 25, 2013", "OCT 17, 2013", "SEP 6, 2013", "AUG 27, 2013", "AUG 16, 2013", "AUG 13, 2013", "JUL 9, 2013", "JUL 9, 2013", "JUL 9, 2013", "SEP 23, 2013", "JUN 21, 2013", "MAY 30, 2013", "MAY 28, 2013", "APR 29, 2013", "FEB 11, 2013", "JAN 29, 2013", "JAN 22, 2013", "JUN 21, 2013", "JAN 7, 2013", "DEC 7, 2012", "DEC 6, 2012", "NOV 15, 2012", "OCT 24, 2012", "OCT 3, 2012", "OCT 2, 2012", "JAN 17, 2013", "AUG 10, 2012", "JUL 31, 2012", "JUL 27, 2012", "JUL 24, 2012", "JUL 12, 2012", "JUN 27, 2012", "MAY 29, 2012", "SEP 11, 2012", "AUG 10, 2012", "NOV 28, 2011", "NOV 25, 2011", "NOV 4, 2011", "JUL 25, 2011", "MAY 12, 2011", "FEB 24, 2011", "MAR 19, 2012", "JAN 7, 2011"], "Published Date": [], "Link": ["https://www.nasdaq.com/articles/amrn-august-7th-options-begin-trading-2020-06-25", "https://www.nasdaq.com/articles/amarin-amrn-stock-will-likely-stay-range-bound-near-term-says-analyst-2020-06-18", "https://www.nasdaq.com/articles/can-amarin-soar-420-over-the-next-year-this-analyst-thinks-so-2020-06-17", "https://www.nasdaq.com/articles/amrn-makes-peace-with-apotex-idya-cuts-deal-with-gsk-slrx-on-watch-nbix-tak-ink-%242bln-pact", "https://www.nasdaq.com/articles/a-stock-to-play-in-a-risk-irrelevant-market-2020-06-16", "https://www.nasdaq.com/articles/pphs-holdings-imply-21-gain-potential-2020-06-16", "https://www.nasdaq.com/articles/july-31st-options-now-available-for-amarin-amrn-2020-06-11", "https://www.nasdaq.com/articles/too-much-uncertainty-keeps-this-5-star-analyst-watching-amarin-stock-from-the-sidelines", "https://www.nasdaq.com/articles/amrn-august-7th-options-begin-trading-2020-06-25", "https://www.nasdaq.com/articles/july-10th-options-now-available-for-amarin-amrn-2020-05-28", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-liveramp-t2-biosystems-foot-locker-2020-05-22", "https://www.nasdaq.com/articles/fda-approves-generic-version-of-amarins-blockbuster-fish-oil-capsules-2020-05-22", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-abbott-tetraphase-pharma-hpe-2020-05-22", "https://www.nasdaq.com/articles/1-biotech-stock-to-avoid-at-all-costs-2020-05-22", "https://www.nasdaq.com/articles/fda-approves-first-generic-version-of-vascepa-amarin-on-watch-2020-05-22", "https://www.nasdaq.com/articles/is-amarin-stock-a-buy-2020-05-19", "https://www.nasdaq.com/articles/will-courts-reverse-earlier-ruling-on-amarin-patents-analyst-weights-in-2020-05-28", "https://www.nasdaq.com/articles/if-you-invested-%2410000-in-amarins-ipo-this-is-how-much-money-youd-have-now-2020-05-09", "https://www.nasdaq.com/articles/amarin-amrn-stock-could-stage-a-rebound-to-%2415-says-analyst-2020-05-05", "https://www.nasdaq.com/articles/amarin-amrn%3A-all-eyes-on-vascepa-appeal-verdict-2020-05-04", "https://www.nasdaq.com/articles/amarin-corporation-plc-amrn-q1-2020-earnings-call-transcript-2020-05-01", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-tesla-valaris-qep-resources-2020-04-30", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-tesla-facebook-valaris-2020-04-30", "https://www.nasdaq.com/articles/2-top-biotech-stocks-under-%2410-2020-04-27", "https://www.nasdaq.com/articles/can-amarin-amrn-overcome-its-patent-headwinds-5-star-analyst-weighs-in-2020-05-15", "https://www.nasdaq.com/articles/can-amarins-stock-recover-from-its-70-implosion-2020-04-18", "https://www.nasdaq.com/articles/should-you-buy-biotech-stocks-right-now-2020-04-15", "https://www.nasdaq.com/articles/buzz-u.s.-stocks-on-the-move-wall-st-banks-u.s.-airlines-casinos-tesla-jj-apple-roku-2020", "https://www.nasdaq.com/articles/amrn-chugs-along-athx-to-initiate-pivotal-covid-19-trial-worx-soars-550-2020-04-13", "https://www.nasdaq.com/articles/amarin-corporation-plc-amrn-q1-2020-earnings-call-transcript-2020-04-14", "https://www.nasdaq.com/articles/why-amarin-stock-is-on-the-mend-today-2020-04-08", "https://www.nasdaq.com/articles/amarin-amrn-will-make-excellent-takeover-target-says-analyst-2020-04-06", "https://www.nasdaq.com/articles/better-buy%3A-amarin-vs.-aurinia-pharmaceuticals-2020-04-19", "https://www.nasdaq.com/articles/why-is-everyone-talking-about-amarin-stock-2020-04-05", "https://www.nasdaq.com/articles/are-amarins-blockbuster-dreams-over-2020-04-04", "https://www.nasdaq.com/articles/2-ultra-high-growth-stocks-id-buy-right-now-2020-04-02", "https://www.nasdaq.com/articles/whats-the-buzz-about-amarin-corp.-amrn-2020-04-02", "https://www.nasdaq.com/articles/why-did-amarins-stock-fall-off-a-cliff-2020-04-02", "https://www.nasdaq.com/articles/judges-record-looks-unpromising-for-amarins-appeal-analyst-remains-bullish-2020-04-01", "https://www.nasdaq.com/articles/is-amarin-stock-a-buy-2020-04-01", "https://www.nasdaq.com/articles/why-amarin-stock-imploded-in-march-2020-04-06", "https://www.nasdaq.com/articles/why-amarin-stock-is-crashing-today-2020-03-31", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-31-2020%3A-amrn-pstv-phge-jnj-pfe-abt-mrk-amgn-2020-03-31", "https://www.nasdaq.com/articles/amrn-loses-legal-fight-akro-awaits-big-day-jnjs-covid-19-vaccine-study-in-sep-2020-03-31", "https://www.nasdaq.com/articles/shares-of-amarin-down-68-after-losing-a-patent-lawsuit-for-vascepa-2020-03-31", "https://www.nasdaq.com/articles/my-top-7-stocks-to-buy-in-marchs-stock-market-crash-2020-03-24", "https://www.nasdaq.com/articles/even-if-it-hurts-amarin-stock-reducing-the-vascepa-sales-push-is-smart-2020-03-20", "https://www.nasdaq.com/articles/3-stocks-to-buy-after-the-coronavirus-crash-2020-03-19", "https://www.nasdaq.com/articles/judicial-ruling-guts-amarin-amrn-stock-whats-next-2020-03-31", "https://www.nasdaq.com/articles/goldman-sachs%3A-3-stocks-to-snap-up-on-the-dip-2020-03-17", "https://www.nasdaq.com/articles/amarin-pulls-back-sales-force-amid-coronavirus-pandemic-2020-03-16", "https://www.nasdaq.com/articles/with-the-market-down-im-buying-these-3-stocks-2020-03-10", "https://www.nasdaq.com/articles/why-its-the-perfect-time-to-buy-amarin-stock-now-2020-03-09", "https://www.nasdaq.com/articles/why-amarin-stock-plunged-in-february-2020-03-06", "https://www.nasdaq.com/articles/6-quality-biotech-stocks-on-sale-now-2020-03-06", "https://www.nasdaq.com/articles/amarin-stock-looks-like-a-heart-healthy-buy-on-the-dip-2020-03-06", "https://www.nasdaq.com/articles/fda-to-postpone-some-inspections-of-u.s.-manufacturing-facilities-2020-03-19", "https://www.nasdaq.com/articles/amarin-stock%3A-when-good-results-arent-enough-2020-03-03", "https://www.nasdaq.com/articles/analysts-anticipate-adru-will-reach-%2425-2020-03-03", "https://www.nasdaq.com/articles/3-big-stock-charts-for-tuesday%3A-amarin-campbell-soup-and-church-dwight-2020-03-03", "https://www.nasdaq.com/articles/look-anywhere-but-acasti-pharma-stock-for-opportunity-2020-02-28", "https://www.nasdaq.com/articles/confounding-decline-creates-an-opportunity-in-amarin-stock-2020-02-28", "https://www.nasdaq.com/articles/amarin-is-now-oversold-amrn-2020-02-27", "https://www.nasdaq.com/articles/4-top-stock-trades-for-thursday%3A-amrn-low-bac-ccl-2020-02-26", "https://www.nasdaq.com/articles/interesting-amrn-put-and-call-options-for-april-24th-2020-03-05", "https://www.nasdaq.com/articles/amarin%3A-is-it-time-to-test-the-waters-2020-02-26", "https://www.nasdaq.com/articles/even-though-its-risky-amarin-stock-is-a-worthwhile-buy-2020-02-26", "https://www.nasdaq.com/articles/acasti-pharma-is-a-risky-play-after-releasing-disappointing-data-2020-02-26", "https://www.nasdaq.com/articles/amarin-corporation-plc-amrn-q4-2019-earnings-call-transcript-2020-02-26", "https://www.nasdaq.com/articles/amarin-reports-q4-results-beats-earnings-and-revenue-targets-2020-02-26", "https://www.nasdaq.com/articles/first-mover-advantage-will-benefit-amarin-stock-more-than-you-think-2020-02-24", "https://www.nasdaq.com/articles/why-amarin-stock-is-getting-no-love-early-in-2020-2020-02-19", "https://www.nasdaq.com/articles/is-it-time-to-give-up-on-amarin-stock-after-earnings-2020-02-26", "https://www.nasdaq.com/articles/6-healthcare-stocks-that-could-make-you-filthy-rich-2020-02-17", "https://www.nasdaq.com/articles/vascepa-growth-will-power-amarin-stock-way-higher-in-2020-2020-02-14", "https://www.nasdaq.com/articles/risks-remain-but-amarin-stock-is-a-buy-at-todays-prices-2020-02-14", "https://www.nasdaq.com/articles/amarins-vascepa-is-a-great-story-filled-with-too-many-unknowns-2020-02-13", "https://www.nasdaq.com/articles/will-positive-patent-news-send-amarin-stock-higher-analysts-fight-it-out-2020-02-12", "https://www.nasdaq.com/articles/bears-are-now-in-control-of-amarin-stock-but-not-for-long-2020-02-12", "https://www.nasdaq.com/articles/4-dates-biotech-investors-should-circle-in-february-2020-02-06", "https://www.nasdaq.com/articles/positive-catalysts-make-amarin-stock-a-buy-on-current-weakness-2020-02-19", "https://www.nasdaq.com/articles/why-amarin-stock-lost-13.4-in-january-2020-02-04", "https://www.nasdaq.com/articles/consider-adding-amarin-to-your-portfolio-as-its-competition-falters-2020-02-04", "https://www.nasdaq.com/articles/acasti-pharma-stock-has-one-last-chance-2020-01-29", "https://www.nasdaq.com/articles/amarin-stock-will-deliver-more-upside-for-patient-investors-2020-01-28", "https://www.nasdaq.com/articles/could-amarin-be-a-millionaire-maker-stock-2020-01-28", "https://www.nasdaq.com/articles/analysts-expect-adru-will-reach-%2424-2020-01-27", "https://www.nasdaq.com/articles/amarin-stock-projections-are-based-on-hype-and-hope-2020-01-27", "https://www.nasdaq.com/articles/does-the-recent-amarin-stock-pullback-put-shares-in-the-buy-category-2020-02-06", "https://www.nasdaq.com/articles/interesting-amrn-put-and-call-options-for-march-6th-2020-01-23", "https://www.nasdaq.com/articles/a-tale-of-3-healthcare-stocks-2-to-buy-and-1-to-sell-2020-01-23", "https://www.nasdaq.com/articles/where-will-intercept-pharmaceuticals-be-in-5-years-2020-01-23", "https://www.nasdaq.com/articles/2-mid-cap-biotech-stocks-to-buy-right-now-2020-01-22", "https://www.nasdaq.com/articles/how-much-is-amarin-really-worth-2020-01-22", "https://www.nasdaq.com/articles/its-time-to-go-long-amarin-stock-after-recent-headlines-2020-01-21", "https://www.nasdaq.com/articles/why-amarin-stock-is-poised-for-a-healthy-2020-2020-01-17", "https://www.nasdaq.com/articles/amarin-stock-is-still-fully-valued-despite-all-the-good-news-2020-01-27", "https://www.nasdaq.com/articles/astrazenecas-loss-is-amarins-big-gain-this-year-2020-01-14", "https://www.nasdaq.com/articles/good-news-for-amarin%3A-astrazeneca-abandoning-its-fish-oil-pill-2020-01-13", "https://www.nasdaq.com/articles/acasti-pharma-stock-could-soar-above-%243-soon-2020-01-13", "https://www.nasdaq.com/articles/2020-j.p.-morgan-healthcare-conference-roundup-2020-01-13", "https://www.nasdaq.com/articles/all-the-2020-pre-jpm-news-healthcare-investors-need-to-know-2020-01-11", "https://www.nasdaq.com/articles/amarin-stock-bouncing-back-after-revised-results-and-2020-guidance-2020-01-10", "https://www.nasdaq.com/articles/7-healthcare-stocks-to-buy-or-sell-as-pricing-pressures-mount-2020-01-10", "https://www.nasdaq.com/articles/after-fda-approval-amarin-stock-is-stuck-in-worrisome-trading-2020-01-16", "https://www.nasdaq.com/articles/september-18th-options-now-available-for-amarin-amrn-2020-01-09", "https://www.nasdaq.com/articles/a-recent-fda-approval-will-be-huge-in-moving-amarin-stock-2020-01-09", "https://www.nasdaq.com/articles/heres-why-matinas-biopharma-shares-lost-as-much-as-16.9-today-2020-01-07", "https://www.nasdaq.com/articles/amarin-reports-preliminary-vascepa-sales-projects-further-growth-in-2020-2020-01-07", "https://www.nasdaq.com/articles/amarin-corporation-amrn%3A-all-eyes-on-vascepa-2020-sales-2020-01-07", "https://www.nasdaq.com/articles/3-high-growth-stocks-that-can-soar-2020-01-06", "https://www.nasdaq.com/articles/is-amarin-stock-a-top-pick-for-2020-2020-01-06", "https://www.nasdaq.com/articles/all-bets-are-off-for-amarin-stock-2020-01-10", "https://www.nasdaq.com/articles/where-to-invest-%2410000-right-now-2020-01-06", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-in-january-2020-01-04", "https://www.nasdaq.com/articles/amrn-february-14th-options-begin-trading-2020-01-02", "https://www.nasdaq.com/articles/health-care-sector-update-for-12-31-2019%3A-amrnhls.tonvcnnvcn.toimacontx-2019-12-31", "https://www.nasdaq.com/articles/vascepas-future-looks-rosy-but-it-could-still-be-fishy-for-amarin-stock-2019-12-31", "https://www.nasdaq.com/articles/health-for-patients-wealth-for-investors%3A-watch-amarin-stock-closely-2019-12-31", "https://www.nasdaq.com/articles/amarin-stock-will-keep-powering-higher-in-2020-2019-12-30", "https://www.nasdaq.com/articles/amarin-stock-primed-for-new-highs-2020-01-06", "https://www.nasdaq.com/articles/3-stocks-that-could-be-the-next-biotech-buyouts-2019-12-23", "https://www.nasdaq.com/articles/amarin-stock-is-at-sky-high-levels-already-assumes-all-the-good-news-2019-12-20", "https://www.nasdaq.com/articles/why-longer-term-investors-should-buy-amarin-stock-on-weakness-2019-12-19", "https://www.nasdaq.com/articles/amarin-has-the-kind-of-future-worth-the-near-term-choppiness-2019-12-18", "https://www.nasdaq.com/articles/3-risks-amarin-still-faces-after-its-huge-fda-win-for-vascepa-2019-12-18", "https://www.nasdaq.com/articles/why-matinas-biopharma-tumbled-13.4-today-2019-12-16", "https://www.nasdaq.com/articles/analyst%3A-with-fda-approval-already-priced-in-avoid-amarin-amrn-stock-2019-12-16", "https://www.nasdaq.com/articles/the-success-of-vascepa-actually-might-be-a-problem-for-amarin-2019-12-30", "https://www.nasdaq.com/articles/is-amarin-a-%2420-billion-stock-2019-12-16", "https://www.nasdaq.com/articles/why-amarin-stock-is-jumping-today-2019-12-16", "https://www.nasdaq.com/articles/better-buy%3A-gilead-sciences-vs.-amgen-2019-12-15", "https://www.nasdaq.com/articles/are-these-biotech-companies-buyout-candidates-deal-or-no-deal-2019-12-14", "https://www.nasdaq.com/articles/amarins-vascepa-gets-fda-approval-for-expanded-use-shares-up-5-2019-12-13", "https://www.nasdaq.com/articles/amarin-has-the-makings-for-a-gamechanging-product-2019-12-13", "https://www.nasdaq.com/articles/3-biotech-stocks-that-can-double-your-money-in-2020-2019-12-11", "https://www.nasdaq.com/articles/amarins-vascepa-approval-seems-fishy-for-patients-and-amrn-investors-2019-12-16", "https://www.nasdaq.com/articles/amarin-stock-has-lower-risk-but-how-much-reward-2019-12-11", "https://www.nasdaq.com/articles/2-top-biotech-buyout-candidates-2019-12-11", "https://www.nasdaq.com/articles/all-eyes-on-these-3-biotech-stocks-ahead-of-fda-decisions-2019-12-09", "https://www.nasdaq.com/articles/4-fda-dates-biotech-investors-should-circle-in-december-2019-12-07", "https://www.nasdaq.com/articles/3-biotechs-facing-fda-approvals-by-years-end-2019-12-07", "https://www.nasdaq.com/articles/biotechs-year-end-to-do-list-2019-12-07", "https://www.nasdaq.com/articles/acquisition-rumors-arent-the-only-thing-moving-amarin-stock-2019-12-06", "https://www.nasdaq.com/articles/amarin-stock-has-lower-risk-but-how-much-reward-2019-12-11-0", "https://www.nasdaq.com/articles/for-now-amarin-stock-is-a-gamble-on-fda-approval-2019-12-04", "https://www.nasdaq.com/articles/biotech-stocks-facing-fda-decision-in-december-2019-2019-12-01", "https://www.nasdaq.com/articles/should-you-sell-or-hold-a-stock-after-a-6x-gain-in-two-days-2019-11-27", "https://www.nasdaq.com/articles/interesting-amrn-put-and-call-options-for-january-2020-2019-11-27", "https://www.nasdaq.com/articles/2-top-biotech-stocks-to-buy-right-now-2019-11-27", "https://www.nasdaq.com/articles/why-did-farallon-capital-get-out-of-these-3-biotech-stocks-2019-11-26", "https://www.nasdaq.com/articles/pphs-holdings-imply-12-gain-potential-2019-11-25", "https://www.nasdaq.com/articles/january-2020-options-now-available-for-amarin-amrn-2019-12-05", "https://www.nasdaq.com/articles/is-amarins-fish-oil-pill-on-track-to-become-a-blockbuster-2019-11-22", "https://www.nasdaq.com/articles/is-amarin-really-a-%247-stock-2019-11-21", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-to-buy-in-november-2019-11-21", "https://www.nasdaq.com/articles/heres-why-amarin-dropped-as-much-as-16.0-today-2019-11-20", "https://www.nasdaq.com/articles/hedge-fund-innovator-joseph-edelman-doubles-down-on-these-3-biotech-stocks-2019-11-20", "https://www.nasdaq.com/articles/looking-for-a-biotech-stock-thats-an-ideal-buyout-candidate-this-is-it.-2019-11-20", "https://www.nasdaq.com/articles/oppenheimer-sees-doom-and-gloom-in-amarin-amrn-stock-2019-11-19", "https://www.nasdaq.com/articles/does-amarin-have-a-dark-horse-suitor-2019-11-24", "https://www.nasdaq.com/articles/why-the-rally-in-amarin-stock-should-hold-strong-2019-11-18", "https://www.nasdaq.com/articles/the-question-is-not-why-amarin-stock-may-go-up-but-should-it-2019-11-18", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-15-2019%3A-pstvtaroamrntorc-2019-11-15", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-15-2019%3A-taroamrntorc-2019-11-15", "https://www.nasdaq.com/articles/health-care-sector-update-for-11-15-2019%3A-torc-agrx-amrn-jnj-pfe-abt-mrk-amgn-2019-11-15", "https://www.nasdaq.com/articles/whats-next-for-amarins-stock-2019-11-15", "https://www.nasdaq.com/articles/amarins-stock-could-reach-%2450-per-share-soon-2019-11-13", "https://www.nasdaq.com/articles/how-much-higher-can-amarin-amrn-stock-go-following-fda-approval-2019-11-18", "https://www.nasdaq.com/articles/why-amarin-ladenburg-thalmann-financial-services-and-pge-jumped-today-2019-11-12", "https://www.nasdaq.com/articles/5-top-stock-trades-for-wednesday%3A-spy-dis-pypl-2019-11-12", "https://www.nasdaq.com/articles/why-amarin-stock-is-crushing-it-today-2019-11-12", "https://www.nasdaq.com/articles/20-stocks-that-could-double-your-money-in-2020-2019-11-11", "https://www.nasdaq.com/articles/theres-an-opportunity-brewing-in-amarin-amrn-stock-ahead-of-vascepas-adcom-says-analyst", "https://www.nasdaq.com/articles/december-27th-options-now-available-for-amarin-amrn-2019-11-07", "https://www.nasdaq.com/articles/is-amarin-a-buy-2019-11-07", "https://www.nasdaq.com/articles/todays-top-5-gainers-in-healthcare-sector-amrn-dmac-tnxp...-2019-11-12", "https://www.nasdaq.com/articles/is-amarin-a-buy-after-a-strong-q3-2019-11-06", "https://www.nasdaq.com/articles/amarin-corporation-plc-amrn-q3-2019-earnings-call-transcript-2019-11-05", "https://www.nasdaq.com/articles/december-13th-options-now-available-for-amarin-amrn-2019-10-31", "https://www.nasdaq.com/articles/biotech-stocks-facing-fda-decision-in-november-2019-2019-10-28", "https://www.nasdaq.com/articles/december-6th-options-now-available-for-amarin-amrn-2019-10-24", "https://www.nasdaq.com/articles/5-strong-buy-biotech-stocks-with-rapidly-approaching-catalysts-2019-10-24", "https://www.nasdaq.com/articles/7-stocks-to-buy-with-100-upside-potential-2019-10-23", "https://www.nasdaq.com/articles/6-reasons-investors-are-nervous-about-amarins-big-date-with-the-fda-2019-11-07", "https://www.nasdaq.com/articles/why-amarin-investors-have-their-eyes-on-nov.-14-2019-10-13", "https://www.nasdaq.com/articles/will-the-pace-of-ma-pick-up-following-the-biotech-sectors-pounding-2019-10-11", "https://www.nasdaq.com/articles/amrn-november-29th-options-begin-trading-2019-10-11", "https://www.nasdaq.com/articles/5-top-stock-trades-for-thursday%3A-irbt-amrn-cgc-2019-10-09", "https://www.nasdaq.com/articles/3-mid-cap-biotech-stocks-to-consider-buying-now-2019-10-04", "https://www.nasdaq.com/articles/amarin-becomes-oversold-amrn-2019-10-03", "https://www.nasdaq.com/articles/how-fishy-is-this-fish-oil-pill-2019-10-02", "https://www.nasdaq.com/articles/2-stocks-that-could-double-your-money-in-2020-2019-10-19", "https://www.nasdaq.com/articles/why-the-healthcare-revolution-should-make-you-rethink-when-youll-claim-social-security", "https://www.nasdaq.com/articles/health-care-sector-update-for-09-16-2019%3A-amrntslaaldracbacb.to-2019-09-16", "https://www.nasdaq.com/articles/why-amarin-stock-dropped-19-in-august-2019-09-11", "https://www.nasdaq.com/articles/amarin%3A-keep-your-dry-powder-ready-2019-09-09", "https://www.nasdaq.com/articles/3-top-healthcare-stocks-to-buy-right-now-2019-08-22", "https://www.nasdaq.com/articles/8-biotech-stocks-to-watch-after-the-q2-earnings-season-2019-08-20", "https://www.nasdaq.com/articles/amarin-becomes-oversold-amrn-2019-08-12", "https://www.nasdaq.com/articles/3-top-biotech-stocks-to-buy-right-now-2019-10-01", "https://www.nasdaq.com/articles/how-the-10-best-stocks-from-last-year-hold-up-today-2019-08-09", "https://www.nasdaq.com/articles/why-amarin-stock-is-tanking-today-2019-08-09", "https://www.nasdaq.com/articles/health-care-sector-update-for-08-09-2019%3A-amrnnvronktr-2019-08-09", "https://www.nasdaq.com/articles/health-care-sector-update-for-08-09-2019%3A-vray-nktr-amrn-jnj-pfe-abt-mrk-amgn-2019-08-09", "https://www.nasdaq.com/articles/fda-to-hold-advisory-committee-hearing-for-amarins-vascepa-snda-stock-fall-22-2019-08-08", "https://www.nasdaq.com/articles/what-youll-want-to-know-about-amarins-strong-q2-results-2019-07-31", "https://www.nasdaq.com/articles/november-15th-options-now-available-for-amarin-amrn-2019-08-12", "https://www.nasdaq.com/articles/3-takeaways-from-amarins-earnings-2019-07-31", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-31-2019%3A-hum-ttoo-amrn-jnj-pfe-abt-mrk-amgn-2019-07-31", "https://www.nasdaq.com/articles/amarin%3A-is-a-buyout-really-off-the-table-2019-07-21", "https://www.nasdaq.com/articles/notable-two-hundred-day-moving-average-cross-amrn-2019-07-19", "https://www.nasdaq.com/articles/why-united-rentals-eagle-bancorp-and-amarin-slumped-today-2019-07-18", "https://www.nasdaq.com/articles/heres-why-amarin-stock-tumbled-today-2019-07-18", "https://www.nasdaq.com/articles/2-incredibly-cheap-biotech-stocks-to-buy-now-2019-07-15", "https://www.nasdaq.com/articles/amarin-corporation-plc-amrn-q2-2019-earnings-call-transcript-2019-07-31", "https://www.nasdaq.com/articles/3-big-stock-charts-for-wednesday%3A-cvs-health-pfizer-and-weyerhaeuser-2019-07-03", "https://www.nasdaq.com/articles/why-maxar-technologies-amarin-and-revolve-group-jumped-today-2019-07-02", "https://www.nasdaq.com/articles/heres-why-amarin-rose-as-much-as-16.3-today-2019-07-02", "https://www.nasdaq.com/articles/5-top-stock-trades-for-wednesday%3A-nke-amrn-gs-2019-07-02", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-02-2019%3A-wmgicuramrnntgn-2019-07-02", "https://www.nasdaq.com/articles/mid-afternoon-market-update%3A-acuity-brands-falls-on-downbeat-sales-amarin-shares-jump-2019", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-02-2019%3A-curamrnntgn-2019-07-02", "https://www.nasdaq.com/articles/why-amarin-stock-is-up-63-so-far-in-2019-2019-07-10", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-02-2019%3A-amrn-cur-iova-jnj-pfe-abt-mrk-amgn-2019-07-02", "https://www.nasdaq.com/articles/2-stocks-that-could-be-the-next-biotech-buyouts-2019-06-29", "https://www.nasdaq.com/articles/5-top-stock-trades-friday%3A-aapl-veev-dg-dltr-2019-05-30", "https://www.nasdaq.com/articles/3-top-mid-cap-stocks-buy-right-now-2019-05-30", "https://www.nasdaq.com/articles/why-cypress-semiconductor-amarin-and-heico-jumped-today-2019-05-29", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-29-2019%3A-evhamrnsolymnk-2019-05-29", "https://www.nasdaq.com/articles/health-care-sector-update-for-05-29-2019%3A-amrnsolymnk-2019-05-29", "https://www.nasdaq.com/articles/amarin-news%3A-why-amrn-stock-is-soaring-today-2019-07-02", "https://www.nasdaq.com/articles/health-care-sector-update-for-07-02-2019%3A-amrn-cur-iova-jnj-pfe-abt-mrk-amgn-2019-07-02", "https://www.nasdaq.com/articles/heres-what-you-need-know-amarins-q1-earnings-update-2019-05-01", "https://www.nasdaq.com/articles/amarin-corporation-plc-amrn-q1-2019-earnings-call-transcript-2019-05-01", "https://www.nasdaq.com/articles/4-more-healthcare-earnings-reports-watch-week-2019-04-30", "https://www.nasdaq.com/articles/amarin-buy-2019-04-21", "https://www.nasdaq.com/articles/amarin-amrn-outpaces-stock-market-gains%3A-what-you-should-know-2019-04-12-0", "https://www.nasdaq.com/articles/european-adrs-move-lower-in-wednesday-trading-2019-04-10", "https://www.nasdaq.com/articles/heres-why-amarin-soared-today-2019-05-29", "https://www.nasdaq.com/articles/fridays-etf-movers-ibb-kre-2019-03-29", "https://www.nasdaq.com/articles/fridays-etf-movers-ibb-kre-2019-03-29-0", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-28-2019%3A-tcdaosmtamrnctst-2019-03-28", "https://www.nasdaq.com/articles/amarin-news-why-amrn-stock-surging-today-2019-03-28", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-28-2019%3A-osmtamrnctst-2019-03-28", "https://www.nasdaq.com/articles/european-adrs-move-lower-in-thursday-trading-2019-03-28", "https://www.nasdaq.com/articles/health-care-sector-update-for-03-28-2019%3A-ctst-amrn-vlrx-jnj-pfe-abt-mrk-amgn-2019-03-28", "https://www.nasdaq.com/articles/amarin-amrn-outpaces-stock-market-gains%3A-what-you-should-know-2019-04-05-0", "https://www.nasdaq.com/articles/health-care-sector-update-03282019-tcdaosmtamrnctst-2019-03-28-0", "https://www.nasdaq.com/articles/amarin-news-why-amrn-stock-surging-today-2019-03-28-0", "https://www.nasdaq.com/articles/health-care-sector-update-03282019-osmtamrnctst-2019-03-28-0", "https://www.nasdaq.com/articles/amarin-no-brainer-stock-buy-dip-2019-03-14", "https://www.nasdaq.com/articles/heres-why-amarin-gained-17-february-2019-03-11", "https://www.nasdaq.com/articles/health-care-sector-update-03052019-pmdacbacbtoamrnadms-2019-03-05", "https://www.nasdaq.com/articles/health-care-sector-update-03052019-amrnacbacbtoadms-2019-03-05", "https://www.nasdaq.com/articles/pre-market-most-active-mar-28-2019-shv-qqq-db-qtna-sqqq-nok-amrn-amd-san-nio-ctst-acb-2019", "https://www.nasdaq.com/articles/amarin-amrn-misses-earnings-beats-revenues-in-q4-2019-02-27", "https://www.nasdaq.com/articles/amarin-corporation-plc-amrn-q4-2018-earnings-conference-call-transcript-2019-02-27", "https://www.nasdaq.com/articles/pre-market-earnings-report-february-27-2019-low-amt-tjx-peg-bby-aes-cpb-ions-amrn-uthr", "https://www.nasdaq.com/articles/how-parts-add-adru-targets-23-2019-02-25", "https://www.nasdaq.com/articles/7-top-analyst-stock-buys-2019-02-18", "https://www.nasdaq.com/articles/whats-in-the-cards-for-amarin-amrn-this-earnings-season-2019-02-18", "https://www.nasdaq.com/articles/2-healthcare-stocks-ripe-takeover-2019-02-17", "https://www.nasdaq.com/articles/amarin-sitting-goldmine-2019-02-28", "https://www.nasdaq.com/articles/amarin-amrn-gains-as-market-dips%3A-what-you-should-know-2019-02-14", "https://www.nasdaq.com/articles/why-amarin-stock-jumped-29-january-after-soaring-239-last-year-2019-02-04", "https://www.nasdaq.com/articles/biggest-biotech-binary-event-2019-just-around-corner-2019-01-29", "https://www.nasdaq.com/articles/why-short-sellers-raised-their-bets-against-2-surging-biotech-stocks-2019-01-28", "https://www.nasdaq.com/articles/do-options-traders-know-something-about-amarin-amrn-stock-we-dont-2019-01-24", "https://www.nasdaq.com/articles/3-stocks-are-absurdly-cheap-right-now-2019-01-23", "https://www.nasdaq.com/articles/adrus-underlying-holdings-could-mean-16-gain-potential-2019-01-22", "https://www.nasdaq.com/articles/7-strong-buy-stocks-with-over-20-upside-2019-02-15", "https://www.nasdaq.com/articles/would-pfizer-shareholders-win-acquisition-amarin-2019-01-20", "https://www.nasdaq.com/articles/why-amarin-stock-skyrocketed-239-2018-and-26-2019-2019-01-14", "https://www.nasdaq.com/articles/3-biotech-stocks-soared-week-are-they-buys-2019-01-12", "https://www.nasdaq.com/articles/amarin-amrn-stock-up-on-rumors-of-acquisition-by-pfizer-2019-01-11", "https://www.nasdaq.com/articles/why-aurora-cannabis-amarin-and-constellation-brands-jumped-today-2019-01-10", "https://www.nasdaq.com/articles/health-care-sector-update-01102019-amrnpfehaloprpocgix-2019-01-10", "https://www.nasdaq.com/articles/thursdays-etf-unusual-volume-adrd-2019-01-10", "https://www.nasdaq.com/articles/3-biotech-stocks-could-be-slapped-us-government-shutdown-2019-01-22", "https://www.nasdaq.com/articles/amarin-down-on-lower-19-view-posts-preliminary-18-results-2019-01-07", "https://www.nasdaq.com/articles/2-healthcare-stocks-buy-week-2019-01-07", "https://www.nasdaq.com/articles/top-healthcare-stocks-2018-can-they-continue-2019-2019-01-03", "https://www.nasdaq.com/articles/these-3-stocks-turned-1000-7000-just-1-year-2019-01-02", "https://www.nasdaq.com/articles/3-biotech-stocks-are-too-cheap-ignore-2018-12-26", "https://www.nasdaq.com/articles/amarin-amrn-gains-as-market-dips%3A-what-you-should-know-2018-12-19", "https://www.nasdaq.com/articles/biotech-stocks-made-big-progress-toward-preventing-heart-attacks-2018-2018-12-18", "https://www.nasdaq.com/articles/amarin-corporations-stock-heats-buyout-chatter-2019-01-10", "https://www.nasdaq.com/articles/7-hot-stocks-buy-cold-market-2018-12-10", "https://www.nasdaq.com/articles/heres-why-amarin-fell-136-november-2018-12-10", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-amarin-amrn-stock-2018-12-07", "https://www.nasdaq.com/articles/5-stocks-buy-and-put-under-your-christmas-tree-2018-12-06", "https://www.nasdaq.com/articles/amarin-amrn-stock-sinks-as-market-gains%3A-what-you-should-know-2018-12-03", "https://www.nasdaq.com/articles/2-biotech-stocks-poised-big-gains-2019-2018-12-03", "https://www.nasdaq.com/articles/serious-questions-surround-cv-sciences-stock-2018-11-30", "https://www.nasdaq.com/articles/implied-adru-analyst-target-price-24-2018-12-18", "https://www.nasdaq.com/articles/why-us-steel-amarin-and-papa-johns-international-slumped-today-2018-11-27", "https://www.nasdaq.com/articles/why-amarins-latest-news-caused-shares-crash-13-today-2018-11-27", "https://www.nasdaq.com/articles/pre-market-most-active-nov-15-2018-agnc-bcs-qqq-cme-acwi-wmt-amd-amrn-ed-baba-nio-kref", "https://www.nasdaq.com/articles/why-amarin-corporation-stock-300-2018-2018-11-15", "https://www.nasdaq.com/articles/why-amarin-corporations-stock-mend-today-2018-11-15", "https://www.nasdaq.com/articles/wednesdays-vital-data-macys-amarin-and-starbucks-2018-11-14", "https://www.nasdaq.com/articles/3-stock-charts-wednesday-home-depot-ppl-and-hollyfrontier-2018-11-14", "https://www.nasdaq.com/articles/pre-market-most-active-nov-27-2018-sqqq-aapl-qqq-amd-amrn-asx-tvix-ibn-stm-nok-nio-kos", "https://www.nasdaq.com/articles/pre-market-most-active-nov-14-2018-bhge-chk-taho-vici-lyg-m-amrn-qqq-amd-sqqq-aapl-tqqq", "https://www.nasdaq.com/articles/amarins-vascepa-cuts-heart-risk-in-outcomes-test-stock-down-2018-11-13", "https://www.nasdaq.com/articles/why-halliburton-tyson-foods-and-amarin-slumped-today-2018-11-13", "https://www.nasdaq.com/articles/heres-why-amarin-corporation-tumbled-20-today-2018-11-13", "https://www.nasdaq.com/articles/why-amarin-corporations-stock-falling-today-2018-11-12", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-amarin-amrn-stock-2018-11-12", "https://www.nasdaq.com/articles/pre-market-most-active-nov-12-2018-amrn-qqq-apti-aapl-amd-sqqq-2018-11-12", "https://www.nasdaq.com/articles/peek-under-hood-adru-has-19-upside-2018-11-14", "https://www.nasdaq.com/articles/pre-market-most-active-nov-14-2018-bhge-chk-taho-vici-lyg-m-amrn-qqq-amd-sqqq-aapl-tqqq", "https://www.nasdaq.com/articles/amarins-vascepa-cuts-heart-risk-in-outcomes-test-stock-down-2018-11-13", "https://www.nasdaq.com/articles/amarin-reaches-analyst-target-price-2018-11-02", "https://www.nasdaq.com/articles/amarin-amrn-beats-earnings-misses-revenues-q3-2018-11-01", "https://www.nasdaq.com/articles/amarin-amrn-gains-as-market-dips%3A-what-you-should-know-2018-10-26", "https://www.nasdaq.com/articles/why-investors-are-paying-premium-these-3-biotech-stocks-2018-10-23", "https://www.nasdaq.com/articles/amarin-amrn-dips-more-than-broader-markets%3A-what-you-should-know-2018-10-19", "https://www.nasdaq.com/articles/tuesdays-vital-data%3A-activision-amarin-and-apple-2018-11-06", "https://www.nasdaq.com/articles/4-strong-stocks-buy-double-big-takeover-targets-2018-10-16", "https://www.nasdaq.com/articles/pre-market-most-active-oct-12-2018-qqq-sqqq-cori-baba-snap-sq-bac-aapl-tqqq-amrn-nio-jpm", "https://www.nasdaq.com/articles/amarin-corporation-plc-buy-2018-10-12", "https://www.nasdaq.com/articles/2-biotech-stocks-on-a-winning-streak-2018-10-11", "https://www.nasdaq.com/articles/amarin-amrn-stock-moves-1.51%3A-what-you-should-know-2018-10-10", "https://www.nasdaq.com/articles/why-amarin-stock-skyrocketed-415-september-2018-10-09", "https://www.nasdaq.com/articles/pre-market-most-active-oct-5-2018-vtvt-qqq-pbr-snap-gpro-amrn-tsla-tvix-abx-cs-chk-san", "https://www.nasdaq.com/articles/314-one-day-and-then-another-58-how-find-next-amarin-2018-10-18", "https://www.nasdaq.com/articles/4-strong-stocks-buy-double-big-takeover-targets-2018-10-16", "https://www.nasdaq.com/articles/heres-why-amarin-corporation-jumped-again-today-2018-10-03", "https://www.nasdaq.com/articles/5-top-healthcare-mutual-funds-to-buy-in-october-2018-10-02", "https://www.nasdaq.com/articles/2-healthcare-stocks-soared-september-can-they-keep-climbing-2018-10-02", "https://www.nasdaq.com/articles/financial-exchange-stock-talk-joe-mccann-amarin-2018-10-02", "https://www.nasdaq.com/articles/5-best-biotech-stocks-to-buy-in-october-2018-10-01", "https://www.nasdaq.com/articles/pre-market-most-active-oct-1-2018-ge-tsla-amrn-f-sqqq-qqq-tlry-aapl-bac-nio-teva-sny-2018", "https://www.nasdaq.com/articles/3-stocks-buy-and-hold-decades-2018-10-03", "https://www.nasdaq.com/articles/healthcare-2-hot-biotech-stocks-our-radar-2018-09-28", "https://www.nasdaq.com/articles/why-bojangles-lions-gate-entertainment-and-amarin-jumped-today-2018-09-28", "https://www.nasdaq.com/articles/why-amarin-rallying-over-10-again-friday-2018-09-28", "https://www.nasdaq.com/articles/amarins-stock-soars-as-fish-oil-drug-lowers-heart-risks-2018-09-27", "https://www.nasdaq.com/articles/3-drugmakers-not-pleased-amarins-fish-oil-triumph-2018-09-26", "https://www.nasdaq.com/articles/biotech-stock-roundup%3A-alxn-soliris-successful-respite-for-sarepta-amrn-soars-2018-09-26", "https://www.nasdaq.com/articles/pre-market-most-active-sep-26-2018-cnp-gpro-azn-qqq-bcs-sq-amrn-nok-nke-tlry-cone-cron", "https://www.nasdaq.com/articles/how-big-could-amarins-vascepa-be-2018-09-30", "https://www.nasdaq.com/articles/pre-market-most-active-sep-25-2018-amrn-snap-ibn-dlr-fb-azn-tlry-cron-abx-bp-qqq-vstm-2018", "https://www.nasdaq.com/articles/biotech-news-why-amarin-stock-going-gangbusters-today-2018-09-24", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-open-lower-siriusxm-buy-pandora-35b-2018-09-24", "https://www.nasdaq.com/articles/it-time-ditch-your-fish-oil-pill-miracle-medicine-2018-09-24", "https://www.nasdaq.com/articles/wall-street-sees-downbeat-session-china-backs-away-trade-talks-2018-09-24", "https://www.nasdaq.com/articles/pre-market-most-active-sep-24-2018-amrn-p-siri-tot-jd-qqq-symc-cmcsa-abx-nio-chk-xon-2018", "https://www.nasdaq.com/articles/forget-tilray-these-two-biotech-stocks-have-far-more-upside-2018-09-25", "https://www.nasdaq.com/articles/tuesdays-vital-data-general-electric-company-snap-and-amarin-2018-09-25", "https://www.nasdaq.com/articles/why-barrick-gold-amarin-and-california-resources-jumped-today-2018-09-24", "https://www.nasdaq.com/articles/after-hours-most-active-sep-24-2018-ge-jnpr-qcom-fcx-fdc-t-mu-f-foxa-qqq-amrn-intc-2018-09", "https://www.nasdaq.com/articles/health-care-sector-update-09242018-anabamrnxontrxc-2018-09-24", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-2-astrotech-shares-plunge-2018-09-24", "https://www.nasdaq.com/articles/health-care-sector-update-09242018-trxcamrnxon-2018-09-24", "https://www.nasdaq.com/articles/us-futures-head-south-china-backs-away-trade-talks-2018-09-24", "https://www.nasdaq.com/articles/why-amarin-corporation-stock-exploding-higher-today-2018-09-24", "https://www.nasdaq.com/articles/big-party-amarin-stock-just-getting-started-2018-09-24", "https://www.nasdaq.com/articles/why-barrick-gold-amarin-and-california-resources-jumped-today-2018-09-24", "https://www.nasdaq.com/articles/after-hours-most-active-sep-24-2018-ge-jnpr-qcom-fcx-fdc-t-mu-f-foxa-qqq-amrn-intc-2018-09", "https://www.nasdaq.com/articles/health-care-sector-update-09242018-anabamrnxontrxc-2018-09-24", "https://www.nasdaq.com/articles/mid-afternoon-market-update-crude-oil-2-astrotech-shares-plunge-2018-09-24", "https://www.nasdaq.com/articles/health-care-sector-update-09242018-trxcamrnxon-2018-09-24", "https://www.nasdaq.com/articles/will-amarin-reward-patient-investors-2018-09-08", "https://www.nasdaq.com/articles/new-deal-moves-mannkind-back-brink-2018-09-06", "https://www.nasdaq.com/articles/3-biotech-stocks-still-have-major-catalysts-september-2018-09-05", "https://www.nasdaq.com/articles/why-amarin-corporation-skyrocketed-239-august-2018-09-03", "https://www.nasdaq.com/articles/3-biotech-stocks-could-soar-next-week-2018-09-02", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-amarin-amrn-stock-2018-04-24", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-amarin-amrn-2018-04-12", "https://www.nasdaq.com/articles/health-care-sector-update-04042018-lly-amrn-gsk-2018-04-04", "https://www.nasdaq.com/articles/now-perfect-time-buy-amarin-corporation-stock-2018-07-11", "https://www.nasdaq.com/articles/why-amarin-corporation-zoomed-10-higher-today-2018-06-28", "https://www.nasdaq.com/articles/is-the-options-market-predicting-a-spike-in-amarin-amrn-stock-2018-05-21", "https://www.nasdaq.com/articles/health-care-sector-update-05022018-amrnuthrzts-2018-05-02", "https://www.nasdaq.com/articles/3-stocks-could-put-teslas-returns-shame-2018-05-01", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-amarin-amrn-stock-2018-04-24", "https://www.nasdaq.com/articles/moving-average-crossover-alert%3A-amarin-amrn-2018-04-12", "https://www.nasdaq.com/articles/health-care-sector-update-04042018-lly-amrn-gsk-2018-04-04", "https://www.nasdaq.com/articles/now-perfect-time-buy-amarin-corporation-stock-2018-07-11", "https://www.nasdaq.com/articles/health-care-sector-update-04042018-snnamrngsklly-2018-04-04", "https://www.nasdaq.com/articles/health-care-sector-update-04042018-amrngsklly-2018-04-04", "https://www.nasdaq.com/articles/implied-volatility-surging-for-amarin-amrn-stock-options-2018-04-02", "https://www.nasdaq.com/articles/3-stocks-could-put-alibabas-returns-shame-2018-03-20", "https://www.nasdaq.com/articles/implied-volatility-surging-for-amarin-amrn-stock-options-2018-03-05", "https://www.nasdaq.com/articles/health-care-sector-update-02272018-mnk-iart-amrn-prgo-exel-2018-02-27", "https://www.nasdaq.com/articles/health-care-sector-update-02272018-iartprgomnkamrn-2018-02-27", "https://www.nasdaq.com/articles/boom-or-bust-news-tap-soon-amarin-2018-04-04", "https://www.nasdaq.com/articles/health-care-sector-update-01302018-amrnimmycrbpaldrbrkabrkbamznjpm-2018-01-30", "https://www.nasdaq.com/articles/implied-analyst-12-month-target-adru-2018-01-26", "https://www.nasdaq.com/articles/amarin-amrn-soars%3A-stock-adds-9.9-in-session-2018-01-24", "https://www.nasdaq.com/articles/why-amarin-corporation-stock-surging-today-2018-01-23", "https://www.nasdaq.com/articles/wall-street-wavers-congress-ends-government-shutdown-2018-01-23", "https://www.nasdaq.com/articles/health-care-sector-update-01232018-jnj-pfe-abt-mrk-amgn-tnxp-vygr-blrx-amgn-celg-2018-01", "https://www.nasdaq.com/articles/pre-market-most-active-jan-23-2018-vz-nflx-vale-qqq-itub-chk-hsbc-san-amrn-tvix-fox-gpro", "https://www.nasdaq.com/articles/health-care-sector-update-02272018-prgomnkamrn-2018-02-27", "https://www.nasdaq.com/articles/amarin-corporation-amrn-in-focus%3A-stock-moves-8.9-higher-2017-12-21", "https://www.nasdaq.com/articles/3-growth-stocks-own-2018-2017-12-18", "https://www.nasdaq.com/articles/10-cheap-stocks-to-buy-with-only-%2412-2017-11-01", "https://www.nasdaq.com/articles/european-adrs-edge-higher-banks-head-north-2017-10-30", "https://www.nasdaq.com/articles/3-small-cap-biotech-stocks-could-be-big-winners-2018-2017-10-19", "https://www.nasdaq.com/articles/tech-bounces-back-2017-09-27", "https://www.nasdaq.com/articles/are-options-traders-betting-on-a-big-move-in-amarin-amrn-stock-2017-08-04", "https://www.nasdaq.com/articles/heres-why-amarin-corporation-plc-rise-today-2017-08-02", "https://www.nasdaq.com/articles/heres-why-amarin-corporation-plc-surged-34-higher-june-2017-07-10", "https://www.nasdaq.com/articles/3-stocks-could-make-you-rich-2017-03-28", "https://www.nasdaq.com/articles/4-biotech-stocks-jaw-dropping-growth-potential-2017-03-21", "https://www.nasdaq.com/articles/heres-what-pushed-amarin-corporation-plc-15-higher-february-2017-03-06", "https://www.nasdaq.com/articles/european-adrs-edge-higher-banks-advance-2017-03-03", "https://www.nasdaq.com/articles/european-adrs-edge-lower-manufacturers-head-south-2017-03-02", "https://www.nasdaq.com/articles/overseas-earnings-estimated-outdo-us-top-5-gainers-2017-04-20", "https://www.nasdaq.com/articles/european-adrs-edge-higher-pharmaceutical-stocks-see-mixed-fortunes-2017-04-17", "https://www.nasdaq.com/articles/3-stocks-smartest-investors-are-buying-right-now-2017-04-07", "https://www.nasdaq.com/articles/3-stocks-could-make-you-rich-2017-03-28", "https://www.nasdaq.com/articles/4-biotech-stocks-jaw-dropping-growth-potential-2017-03-21", "https://www.nasdaq.com/articles/3-small-cap-biotech-stocks-on-the-rise-in-2017-2016-12-14", "https://www.nasdaq.com/articles/7-underdog-stocks-were-watching-closely-2016-12-13", "https://www.nasdaq.com/articles/penny-stocks-2-buy-2-avoid-2016-11-20", "https://www.nasdaq.com/articles/more-innovation-less-regulation-2-biotech-stocks-could-soar-2017-2017-01-11", "https://www.nasdaq.com/articles/1-reason-amarins-stock-skyrocketed-2016-2017-01-10", "https://www.nasdaq.com/articles/health-care-sector-update-11152016-amrnjnpagntsro-2016-11-15", "https://www.nasdaq.com/articles/european-adrs-edge-lower-pharma-stocks-see-mixed-fortunes-2016-11-08", "https://www.nasdaq.com/articles/amarins-stock-buckled-october-it-now-bargain-2016-11-08", "https://www.nasdaq.com/articles/3-important-things-you-need-know-about-amarins-q3-results-2016-11-03", "https://www.nasdaq.com/articles/european-adrs-edge-lower-pharma-stocks-post-mixed-fortunes-2016-10-28", "https://www.nasdaq.com/articles/european-adrs-edge-higher-financial-services-stocks-post-gains-2016-10-24", "https://www.nasdaq.com/articles/patterson-companies-pdco-q2-earnings%3A-whats-in-store-2016-11-17", "https://www.nasdaq.com/articles/teva-trisenox-wins-chmp-nod-for-expanded-use-in-leukemia-2016-10-18", "https://www.nasdaq.com/articles/tetraphase-begins-phase-iii-dosing-of-antibiotic-candidate-2016-10-17", "https://www.nasdaq.com/articles/allergans-belkyra-gets-swedish-approval-for-double-chin-2016-10-17", "https://www.nasdaq.com/articles/sunesis-submits-response-to-questions-on-leukemia-drug-2016-10-14", "https://www.nasdaq.com/articles/oncogenex-cancer-drug-fails-in-phase-iii-study-stock-down-2016-10-14", "https://www.nasdaq.com/articles/intellia-therapeutics-ntla-looks-good%3A-stock-gains-9.9-2016-10-14", "https://www.nasdaq.com/articles/amag-issues-encouraging-updates-on-makena-feraheme-2016-10-13", "https://www.nasdaq.com/articles/astrazenecas-hyperkalemia-drug-nda-resubmission-accepted-2016-10-19", "https://www.nasdaq.com/articles/5-small-cap-stocks-buy-october-2016-10-01", "https://www.nasdaq.com/articles/will-amarin-amrn-continue-to-surge-higher-2016-09-29", "https://www.nasdaq.com/articles/amarin-corporation-amrn-looks-good%3A-stock-adds-6.1-in-session-2016-09-27", "https://www.nasdaq.com/articles/biotech-stocks-under-5-2-buy-1-avoid-2016-09-24", "https://www.nasdaq.com/articles/european-adrs-fractionally-higher-pharma-stocks-rally-2016-09-20", "https://www.nasdaq.com/articles/european-adrs-marginally-lower-telecom-stocks-and-banks-retreat-2016-09-12", "https://www.nasdaq.com/articles/allergan-gets-priority-review-for-avycaz-label-expansion-2016-10-13", "https://www.nasdaq.com/articles/european-adrs-edge-higher-printer-manufacturers-post-gains-2016-09-07", "https://www.nasdaq.com/articles/zacks.com-featured-highlights%3A-amarin-compugen-raptor-pharmaceuticals-arcelormittal-and", "https://www.nasdaq.com/articles/forget-gilead-sciences-inc-these-3-stocks-are-better-buys-2016-09-07", "https://www.nasdaq.com/articles/explosive-stocks-under-10-2016-09-06", "https://www.nasdaq.com/articles/amarin-amrn-ends-patient-randomization-in-vascepa-study-2016-09-01", "https://www.nasdaq.com/articles/is-amarin-corporation-stock-a-solid-choice-right-now-2016-08-31", "https://www.nasdaq.com/articles/mid-day-market-update-dow-surges-over-100-points-caesars-entertainment-shares-slide-2016", "https://www.nasdaq.com/articles/why-polaris-industries-amarin-and-vimpelcom-slumped-today-2016-09-12", "https://www.nasdaq.com/articles/after-hours-most-active-aug-12-2016-amrn-bac-ftr-teva-exc-qqq-ver-sdrl-avp-symc-msft-myl", "https://www.nasdaq.com/articles/pre-market-most-active-aug-11-2016-clf-baba-vrx-brx-m-nrz-yhoo-mxim-amrn-xiv-nflx-dnkn", "https://www.nasdaq.com/articles/why-shake-shack-amarin-and-valeant-pharmaceuticals-slumped-today-2016-08-11", "https://www.nasdaq.com/articles/pre-market-most-active-aug-4-2016-nok-chk-azn-sq-cp-foxa-bac-gold-aapl-alim-amrn-xiv-2016", "https://www.nasdaq.com/articles/health-care-sector-update-08042016-jnj-pfe-abt-mrk-amgn-amrn-sgmo-2016-08-04", "https://www.nasdaq.com/articles/mid-morning-market-update-markets-mostly-higher-tesla-acquire-solarcity-2016-08-01", "https://www.nasdaq.com/articles/mid-afternoon-market-update-trina-solar-gains-following-go-private-deal-insperity-shares", "https://www.nasdaq.com/articles/after-hours-most-active-aug-22-2016-abbv-csco-xom-ldos-amrn-syf-bsm-symc-oas-tlt-qqq-amat", "https://www.nasdaq.com/articles/european-adrs-extend-gains-manufacturers-advance-2016-07-13", "https://www.nasdaq.com/articles/3-risky-biotech-stocks-could-make-you-rich-2016-07-12", "https://www.nasdaq.com/articles/european-adrs-extend-gains-pharma-stocks-surge-2016-06-28", "https://www.nasdaq.com/articles/tiny-biopharma-has-been-bucking-downtrend-2016-06-27", "https://www.nasdaq.com/articles/amarin-amrn-looks-good%3A-stock-adds-6.7-in-session-2016-06-03", "https://www.nasdaq.com/articles/why-amarin-marketo-and-westar-energy-jumped-today-2016-05-31", "https://www.nasdaq.com/articles/2-biotech-stocks-under-5-jaw-dropping-growth-potential-2016-05-30", "https://www.nasdaq.com/articles/european-adrs-edge-higher-banking-stocks-log-gains-2016-07-29", "https://www.nasdaq.com/articles/european-adrs-edge-lower-manufacturing-stocks-post-contractions-2016-05-06", "https://www.nasdaq.com/articles/european-adrs-edge-lower-pharma-stocks-retreat-2016-05-05", "https://www.nasdaq.com/articles/european-adrs-marginally-higher-pharma-stocks-see-mixed-fortunes-2016-05-02", "https://www.nasdaq.com/articles/european-adrs-edge-higher-thursday-trading-2016-04-14", "https://www.nasdaq.com/articles/3-biotech-stocks-scary-high-debt-capital-ratios-2016-04-11", "https://www.nasdaq.com/articles/european-adrs-edge-higher-semiconductor-pharma-stocks-see-mixed-fortunes-2016-03-30", "https://www.nasdaq.com/articles/european-adrs-edge-lower-commodities-stocks-retreat-2016-03-15", "https://www.nasdaq.com/articles/european-adrs-modestly-higher-pharma-gains-offset-mining-losses-2016-05-09", "https://www.nasdaq.com/articles/health-care-sector-update-03092016-amrnadrostem-2016-03-09", "https://www.nasdaq.com/articles/european-adrs-rise-italian-furniture-manufacturer-natuzzi-surges-8-cent-2016-03-09", "https://www.nasdaq.com/articles/european-adrs-edge-telecommunication-stocks-see-mixed-fortunes-2016-02-16", "https://www.nasdaq.com/articles/3-reasons-behind-amarins-strong-2015-2016-01-13", "https://www.nasdaq.com/articles/european-adrs-slip-lower-pharmaceutical-stocks-drive-moves-2015-12-24", "https://www.nasdaq.com/articles/wednesdays-etf-unusual-volume-gwx-2015-11-25", "https://www.nasdaq.com/articles/european-adrs-advance-industrial-products-manufacturers-gain-2015-10-28", "https://www.nasdaq.com/articles/7-top-stocks-buy-march-2016-03-15", "https://www.nasdaq.com/articles/european-adrs-lower-education-company-pearson-sees-shares-slump-2015-10-21", "https://www.nasdaq.com/articles/european-adrs-marginally-higher-oil-and-gas-production-companies-advance-2015-10-01", "https://www.nasdaq.com/articles/european-adrs-trade-two-year-low-miners-contract-2015-09-28", "https://www.nasdaq.com/articles/european-adrs-log-marginal-gains-pharma-stocks-see-mixed-fortunes-2015-09-02", "https://www.nasdaq.com/articles/3-battleground-biotech-stocks-i-would-avoid-all-costs-2015-08-28", "https://www.nasdaq.com/articles/european-adrs-advance-mining-stocks-extend-rally-2015-08-27", "https://www.nasdaq.com/articles/european-adrs-lower-pharma-losses-fail-offset-mining-rally-2015-08-20", "https://www.nasdaq.com/articles/10-cheap-stocks-under-10-buy-2016-2015-10-27", "https://www.nasdaq.com/articles/european-adrs-trade-higher-health-care-companies-advance-2015-07-29", "https://www.nasdaq.com/articles/european-adrs-retreat-miners-pull-back-2015-07-24", "https://www.nasdaq.com/articles/european-adr-slide-oil-stocks-edge-lower-2015-07-17", "https://www.nasdaq.com/articles/european-adrs-make-modest-gains-mining-losses-partially-offset-higher-oil-stocks-2015-07", "https://www.nasdaq.com/articles/3-things-you-should-know-about-amarin-plc-2015-07-11", "https://www.nasdaq.com/articles/european-adrs-trade-lower-financial-services-stocks-slide-2015-07-08", "https://www.nasdaq.com/articles/european-adrs-ebb-pharma-stocks-contract-2015-06-26", "https://www.nasdaq.com/articles/why-amarin-corporation-plc-adr-moving-higher-today-2015-08-07", "https://www.nasdaq.com/articles/european-adrs-slide-banking-stocks-trade-lower-2015-06-15", "https://www.nasdaq.com/articles/3-biotech-stocks-i-wont-buy-2015-06-13", "https://www.nasdaq.com/articles/european-adrs-trade-lower-pharma-stocks-slide-2015-06-09", "https://www.nasdaq.com/articles/amarin-corporation-plc-shares-lifted-may-heres-why-2015-06-05", "https://www.nasdaq.com/articles/european-adrs-trade-lower-oil-stocks-feel-pinch-2015-06-01", "https://www.nasdaq.com/articles/european-adrs-fall-lower-pharma-stocks-dominate-trading-2015-05-29", "https://www.nasdaq.com/articles/amarin-amrn-in-focus%3A-stock-surges-19-in-session-tale-of-the-tape-2015-05-29", "https://www.nasdaq.com/articles/european-adrs-gain-traction-retail-stocks-surge-2015-06-23", "https://www.nasdaq.com/articles/why-shares-amarin-corporation-plc-are-soaring-2015-05-28", "https://www.nasdaq.com/articles/why-amarin-corporation-amrn-could-be-positioned-for-a-slump-tale-of-the-tape-2015-05-18", "https://www.nasdaq.com/articles/which-these-growth-stocks-most-worthy-your-money-2015-05-16", "https://www.nasdaq.com/articles/european-adrs-fractionally-higher-pharmaceuticals-stocks-gain-2015-05-04", "https://www.nasdaq.com/articles/case-you-missed-it-new-study-suggests-america-nation-couch-potatoes-2015-05-03", "https://www.nasdaq.com/articles/european-adrs-contract-tech-stock-losses-weigh-2015-04-30", "https://www.nasdaq.com/articles/european-adrs-trading-lower-despite-mining-gains-2015-04-28", "https://www.nasdaq.com/articles/amarin-corporation-plc-stock-about-double-2015-05-29", "https://www.nasdaq.com/articles/how-amarin-corporation-amrn-stock-stands-out-in-a-strong-industry-tale-of-the-tape-2015-04", "https://www.nasdaq.com/articles/heres-lowdown-amarin-corporation-plcs-55-move-higher-march-2015-04-07", "https://www.nasdaq.com/articles/3-biotech-stocks-danger-running-out-cash-2015-04-02", "https://www.nasdaq.com/articles/european-adrs-flat-pharma-gains-are-outweighed-mining-losses-2015-03-27", "https://www.nasdaq.com/articles/should-investors-toss-towel-amarin-corp-plc-2015-03-26", "https://www.nasdaq.com/articles/european-adrs-higher-eurozone-growth-gathers-pace-2015-03-24", "https://www.nasdaq.com/articles/biotech-stocks-2-avoid-1-buy-2015-03-22", "https://www.nasdaq.com/articles/why-amarin-corp-plc-slumped-today-2015-04-28", "https://www.nasdaq.com/articles/european-adrs-gain-pharma-stocks-pick-momentum-2015-03-18", "https://www.nasdaq.com/articles/why-amarin-corporation-plc-burst-today-2015-03-17", "https://www.nasdaq.com/articles/european-adrs-lower-telecom-companies-slide-2015-03-17", "https://www.nasdaq.com/articles/after-hours-most-active-mar-17-2015-hsic-amrn-orcl-fitb-f-pbr-bwld-bac-utx-adbe-pbra-aapl", "https://www.nasdaq.com/articles/european-adrs-start-week-higher-pharma-stocks-gain-2015-03-16", "https://www.nasdaq.com/articles/pre-market-most-active-mar-16-2015-amrn-slxp-tvix-rdsb-fxcm-bac-xiv-qqq-aapl-ltm-mt-nok", "https://www.nasdaq.com/articles/after-hours-most-active-mar-16-2015-dhr-jd-qqq-hot-apc-ibn-depo-htz-hlt-amrn-intc-ftsm", "https://www.nasdaq.com/articles/european-adrs-lower-despite-mixed-results-oil-stocks-2015-03-19", "https://www.nasdaq.com/articles/pre-market-most-active-mar-12-2015-bac-ll-acad-hsbc-eqm-cybr-c-aapl-qqq-ko-amrn-tvix-2015", "https://www.nasdaq.com/articles/why-amarin-corporation-plc-soared-48-february-2015-03-06", "https://www.nasdaq.com/articles/earnings-reaction-history-amarin-corp-429-follow-through-indicator-66-sensitive-2015-03-03", "https://www.nasdaq.com/articles/whats-in-store-for-geron-gern-this-earnings-season-analyst-blog-2015-03-02", "https://www.nasdaq.com/articles/intercept-pharmaceuticals-icpt-will-it-miss-q4-earnings-analyst-blog-2015-02-28", "https://www.nasdaq.com/articles/will-stratasys-ssys-disappoint-this-earnings-season-analyst-blog-2015-02-27", "https://www.nasdaq.com/articles/european-adrs-end-week-two-and-half-month-high-2015-02-27", "https://www.nasdaq.com/articles/why-amarin-corporation-plc-blasted-higher-2015-03-12", "https://www.nasdaq.com/articles/will-endo-internationas-endp-beat-on-earnings-in-q4-analyst-blog-2015-02-27", "https://www.nasdaq.com/articles/will-mylan-myl-beat-earnings-on-new-product-launches-analyst-blog-2015-02-27", "https://www.nasdaq.com/articles/what-awaits-keryx-biopharmaceuticals-kerx-this-earnings-analyst-blog-2015-02-26", "https://www.nasdaq.com/articles/why-amarin-corporation-plc-surged-higher-today-2015-02-26", "https://www.nasdaq.com/articles/will-epizyme-epzm-miss-estimates-this-earnings-season-analyst-blog-2015-02-25", "https://www.nasdaq.com/articles/should-you-buy-amarin-corporation-amrn-ahead-of-earnings-tale-of-the-tape-2015-02-25", "https://www.nasdaq.com/articles/whats-in-store-for-omnivision-ovti-this-earnings-analyst-blog-2015-02-24", "https://www.nasdaq.com/articles/will-arena-pharmaceuticals-arna-disappoint-on-q4-earnings-analyst-blog-2015-02-27", "https://www.nasdaq.com/articles/will-aegerion-aegr-miss-earnings-estimates-this-season-analyst-blog-2015-02-24", "https://www.nasdaq.com/articles/will-ingram-micro-im-miss-earnings-estimates-in-q4-analyst-blog-2015-02-24", "https://www.nasdaq.com/articles/can-the-uptrend-continue-for-amarin-amrn-tale-of-the-tape-2015-02-23", "https://www.nasdaq.com/articles/european-adrs-higher-mid-week-mixed-performance-pharma-stocks-2015-02-18", "https://www.nasdaq.com/articles/why-amarin-corporation-shares-are-sky-rocketing-2015-02-18", "https://www.nasdaq.com/articles/european-adrs-lifted-pharmaceutical-stock-gains-2014-12-24", "https://www.nasdaq.com/articles/why-amarin-corporation-plc-stock-flew-37-higher-november-2014-12-01", "https://www.nasdaq.com/articles/merrimack-pharmaceuticals-mack%3A-a-miss-this-earnings-analyst-blog-2015-02-24", "https://www.nasdaq.com/articles/amarin-plunges-after-the-fda-denies-vascepa-spa-appeal-analyst-blog-2014-09-15", "https://www.nasdaq.com/articles/markets-drop-darden-adjusted-profit-beats-street-view-2014-09-12", "https://www.nasdaq.com/articles/why-amarin-corporation-plc-stock-cratered-2014-09-12", "https://www.nasdaq.com/articles/us-stocks-poised-lower-open-amid-larger-expected-drop-export-prices-retail-rise-meets", "https://www.nasdaq.com/articles/dow-falls-over-100-points-ulta-salon-shares-jump-after-earnings-report-2014-09-12", "https://www.nasdaq.com/articles/conversant-shares-rise-acquisition-news-health-care-reit-drops-2014-09-12", "https://www.nasdaq.com/articles/european-adrs-pulled-down-contractions-pharmaceutical-stocks-2014-09-11", "https://www.nasdaq.com/articles/amarin-corporation-plc-amrn-in-focus%3A-stock-soars-23.4-tale-of-the-tape-2014-11-19", "https://www.nasdaq.com/articles/biotech-investing-3-ways-youre-doing-it-wrong-2014-08-24", "https://www.nasdaq.com/articles/noteworthy-option-trades-equities-2014-08-18", "https://www.nasdaq.com/articles/shire-retreats-second-day-abbvies-revised-bid-european-adrs-decline-portugal-telecom-gains", "https://www.nasdaq.com/articles/european-adrs-post-broad-declines-after-european-markets-weaken-german-uk-economic-data", "https://www.nasdaq.com/articles/amarin-leads-gains-european-adrs-after-favorable-journal-article-nokia-down-amazoncom", "https://www.nasdaq.com/articles/european-adrs-show-broad-declines-after-regions-markets-pressured-2014-06-11", "https://www.nasdaq.com/articles/ligand-astrazeneca-collaborate-analyst-blog-2014-05-19", "https://www.nasdaq.com/articles/corrected-european-adrs-higher-banking-gains-2014-08-25", "https://www.nasdaq.com/articles/largest-option-trades-equities-2014-04-01", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-flat-pre-market-trade-amarin-partners-kowa-promote-vascepa", "https://www.nasdaq.com/articles/sector-update-healthcares-2014-04-01", "https://www.nasdaq.com/articles/amarins-vascepa-gets-3-year-exclusivity-analyst-blog-2014-02-24", "https://www.nasdaq.com/articles/amarin-tumbles-after-dmep-decision-analyst-blog-2014-01-22", "https://www.nasdaq.com/articles/biotech-stock-roundup-sarepta-spikes-data-alnylam-deal-analyst-blog-2014-01-22", "https://www.nasdaq.com/articles/pre-market-most-active-jan-16-2014-bby-bac-c-bhp-jcp-fox-resi-srpt-fb-amrn-mu-drys-2014-01", "https://www.nasdaq.com/articles/earnings-reaction-history-amarin-corp-571-follow-through-indicator-69-sensitive-2014-05-09", "https://www.nasdaq.com/articles/update-on-amarins-vascepa-analyst-blog-2013-12-27", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-mixed-pre-market-amarin-soars-15-labeling-expansion", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-12-20-0", "https://www.nasdaq.com/articles/mid-day-market-update-sandisk-surges-upbeat-results-ibm-shares-tumble-2013-10-17", "https://www.nasdaq.com/articles/sector-update-healthcare-stocks-lower-united-health-down-3-quarterly-results-2013-10-17", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-10-17-1", "https://www.nasdaq.com/articles/pre-market-most-active-oct-17-2013-amrn-svu-bac-pact-fb-auo-smfg-ebay-nok-ibm-qqq-vod-2013", "https://www.nasdaq.com/articles/after-hours-most-active-jan-15-2014-c-jpm-wfc-f-bac-met-qqq-msft-mu-siri-amrn-spil-2014-01", "https://www.nasdaq.com/articles/pre-market-most-active-oct-14-2013-bac-alu-fb-amd-siri-qqq-mu-vod-gfi-hmy-amrn-phg-2013-10", "https://www.nasdaq.com/articles/heatlhcare-stock-moderately-higher-near-close-amarin-slumps-after-fda-questions-trial", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-10-11-0", "https://www.nasdaq.com/articles/biotech-stocks-continue-recent-downtrend-ariad-tumbles-lowest-price-nearly-three-years", "https://www.nasdaq.com/articles/update-on-amarin-study-analyst-blog-2013-09-26", "https://www.nasdaq.com/articles/sector-update-healthcare-stocks-flat-pre-market-syngeva-prices-public-offering-2013-09-25", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-09-25-1", "https://www.nasdaq.com/articles/fda-not-in-favor-of-amarins-vascepa-analyst-blog-2013-10-17", "https://www.nasdaq.com/articles/amarin-corporation-amrn-in-focus%3A-stock-moves-higher-by-8-analyst-blog-2013-09-06", "https://www.nasdaq.com/articles/can-the-recent-uptrend-continue-for-amarin-corporation-plc-amrn-tale-of-the-tape-2013-08", "https://www.nasdaq.com/articles/positive-data-on-mannkinds-afrezza-analyst-blog-2013-08-16", "https://www.nasdaq.com/articles/wider-than-expected-loss-at-mannkind-analyst-blog-2013-08-13", "https://www.nasdaq.com/articles/pre-market-most-active-jul-9-2013-siri-bp-aa-apu-bac-nok-amrn-kndi-htsi-spil-dell-cone", "https://www.nasdaq.com/articles/benzinga-market-primer-tuesday-july-9-china-inflation-better-expected-2013-07-09", "https://www.nasdaq.com/articles/amarin-offers-american-depositary-shares-analyst-blog-2013-07-09", "https://www.nasdaq.com/articles/largest-option-trades-equities-2013-09-23", "https://www.nasdaq.com/articles/sector-update-healthcare-2013-06-21-1", "https://www.nasdaq.com/articles/pre-market-most-active-may-30-2013-nve-clwr-s-mtu-fb-bac-nj-emc-vnr-qqq-amrn-fslr-2013-05", "https://www.nasdaq.com/articles/largest-option-buying-equities-so-far-2013-05-28", "https://www.nasdaq.com/articles/amarins-performance-issues-here-stay-2013-04-29", "https://www.nasdaq.com/articles/bulls-taking-another-shot-amarin-2013-02-11", "https://www.nasdaq.com/articles/dow-muscles-higher-again-next-stop-14000-2013-01-29", "https://www.nasdaq.com/articles/how-one-large-bull-playing-amarin-2013-01-22", "https://www.nasdaq.com/articles/sector-update-healthcare-shares-higher-pre-market-amarin-3-vascepa-trial-results-2013-06", "https://www.nasdaq.com/articles/weekly-guru-bargains-highlights-panl-thrx-znga-lorl-amrn-2013-01-07", "https://www.nasdaq.com/articles/pre-market-most-active-dec-7-2012-bac-qqq-nok-amrn-vntv-avgo-memp-aapl-fb-san-c-fcx-2012", "https://www.nasdaq.com/articles/after-hours-most-active-dec-6-2012-mmr-bx-qqq-s-amrn-ephc-bac-emc-aig-dish-linta-orcl-2012", "https://www.nasdaq.com/articles/upcoming-biopharma-catalyst-trades-consider-2012-11-15", "https://www.nasdaq.com/articles/pre-market-most-active-oct-24-2012-fb-siri-emc-bac-qqq-gild-dow-znga-mm-bp-seh-amrn-2012", "https://www.nasdaq.com/articles/largest-option-buying-equities-so-far-2012-10-03", "https://www.nasdaq.com/articles/trader-has-bullish-formula-amarin-2012-10-02", "https://www.nasdaq.com/articles/amrn-aims-to-fortify-vascepa-patent-analyst-blog-2013-01-17", "https://www.nasdaq.com/articles/why-investor-wants-be-rid-amarin-2012-08-10", "https://www.nasdaq.com/articles/largest-option-buying-equities-so-far-2012-07-31", "https://www.nasdaq.com/articles/pre-market-most-active-jul-27-2012-fb-siri-amrn-auth-bac-gdot-nok-s-armh-sbux-aci-nxy-2012", "https://www.nasdaq.com/articles/bearish-trade-targets-amarin-after-rally-2012-07-24", "https://www.nasdaq.com/articles/after-hours-most-active-jul-12-2012-qqq-bac-aa-wm-twtc-amd-aol-nly-win-msft-atvi-amrn-2012", "https://www.nasdaq.com/articles/pre-market-most-active-jun-27-2012-eric-amrn-bac-fb-abb-jnj-tkc-nok-omer-arna-nvo-znga", "https://www.nasdaq.com/articles/pre-market-most-active-may-29-2012-vrtx-bac-nok-lcry-fb-gnom-std-bhp-grfs-amrn-bud-c-2012", "https://www.nasdaq.com/articles/pre-market-most-active-sep-11-2012-aig-nok-bp-san-ing-bac-aapl-amrn-gmcr-fb-qqq-fsc-2012", "https://www.nasdaq.com/articles/company-news-for-november-28-2011-corporate-summary-2011-11-28", "https://www.nasdaq.com/articles/top-goldman-sachs-analyst-sovereign-risk-spreading-wildfire-2011-11-28", "https://www.nasdaq.com/articles/mid-day-update-stocks-sitting-higher-black-friday-rally-europe-concern-lingers-2011-11-25", "https://www.nasdaq.com/articles/largest-option-buying-equities-so-far-2011-11-04", "https://www.nasdaq.com/articles/centenarians-health-services-stocks-hedge-fund-buying-2011-07-25", "https://www.nasdaq.com/articles/amarin-spread-sees-good-prognosis-2011-05-12", "https://www.nasdaq.com/articles/playing-range-short-strangles-2011-02-24", "https://www.nasdaq.com/articles/volatility-play-sees-amarin-settling-down-2012-03-19", "https://www.nasdaq.com/articles/sellers-see-calmer-times-amarin-2011-01-07"], "Content": []}